Pilonidal cyst

L12_PILONIDALCYST

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L05 Hospital discharge: ICD-9 — 685 Cause of death: ICD-10 — L05 Cause of death: ICD-9 — 685 2 out of 7 registries used, show all original rules.	4356
4. Check minimum number of events None	4356
5. Include endpoints None	4356
6. Filter based on genotype QC (FinnGen only)	3915

Control definitions (FinnGen only)

Control exclude: L12_INFECT_SKIN

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L00-L08
Name in latin: Cysta pilonidalis

NAME	L12_PILONIDALCYST
CONTROL_EXCLUDE	L12_INFECT_SKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L05
HD_ICD_9	685
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L05
COD_ICD_9	685
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pilonidal cyst based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	37426	10491	26770
Only index persons	36039	10189	25850
Unadjusted period prevalence (%)
Whole population	0.62	0.30	0.75
Only index persons	0.81	0.37	0.99
Median age at first event (years)
Whole population	26.92	24.70	27.76
Only index persons	26.75	24.65	27.58

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3915	1501	2414
Unadjusted period prevalence (%)	0.89	0.53	1.11
Median age at first event (years)	29.58	26.52	31.48

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4080: Matched controls
40800

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

6850A

ICD-9 Finland

Pilonidal cyst, With abscess

+∞

320.1

303

9733

FHL

Excision of skin change in operating room or anesthesia

19.4

310.1

245

134

L05.9

ICD-10 Finland

Pilonidal cyst without abscess

2412.5

307.7

2394

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

21.7

307.7

1477

1038

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

29.2

307.7

647

262

S10

ICPC

Boil/carbuncle

9.7

307.7

774

965

L05.0

ICD-10 Finland

Pilonidal cyst with abscess

702.3

307.7

1507

QBA10

NOMESCO Finland

Incision of skin of trunk

58.0

307.7

301

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

25.0

307.7

397

175

L05

ICD-10 Finland

Pilonidal cyst

182.1

307.7

191

6851A

ICD-9 Finland

Pilonidal cyst, Without mention of abscess

+∞

307.7

791

9736

FHL

Subcutaneous tumor removal in operating room or anesthesia

31.6

307.7

321

110

S85

ICPC

Pilonidal cyst/fistula

96.6

269.2

140

L73.2

ICD-10 Finland

Hidradenitis suppurativa

15.6

263.8

232

157

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

7.2

258.8

407

619

9749

FHL

Other measure in this category

50.1

250.9

145

D95

ICPC

Anal fissure/perianal abscess

15.1

235.0

210

146

SPAT1148

SPAT

Treatment of chronic ulcer or burn

4.3

217.9

634

1669

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

7.9

214.0

305

414

J01FF01

ATC

clindamycin; systemic

2.9

205.0

1399

6267

P01AB01

ATC

metronidazole; oral, rectal

2.6

192.7

1843

9729

K61.0

ICD-10 Finland

Anal abscess

8.5

190.7

252

312

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

7.0

168.5

264

397

QBE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of trunk

60.6

159.8

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

4.7

150.6

369

841

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

4.9

147.7

346

760

J01DA01

ATC

[U] cefalexin

2.4

141.5

2697

18474

J01DB01

ATC

cefalexin; oral

3.4

138.4

3645

28943

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.8

133.5

252

456

K60.3

ICD-10 Finland

Anal fistula

6.9

133.2

210

317

S97

ICPC

Chronic ulcer skin

4.7

113.4

274

615

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

7.9

110.2

153

200

9731

FHL

Opening and channeling of the inflammatory site in the operating room or anesthesia

22.6

109.4

SPAT1146

SPAT

Puncture of abscess or incision of skin

7.5

101.4

147

202

QBG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of trunk

56.8

99.1

S18

ICPC

Laceration/cut

1.9

89.3

1806

11853

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

14.9

85.4

9734

FHL

Excision and local plastic or associated free skin grafting

18.2

84.6

JHA00

NOMESCO Finland

Anal or perianal incision

6.1

81.3

143

241

103

Kela drug reimbursment

Diabetes, insulin-treated

2.1

74.5

918

5012

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.0

70.1

885

4862

J01DA09

ATC

[U] cefadroxil

1.9

67.1

1127

6815

L72.1

ICD-10 Finland

Trichilemmal cyst

2.8

66.9

355

1331

WX320

NOMESCO Finland

Spinalanesthesy

2.0

66.7

858

4736

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.4

62.3

461

2033

N02AX02

ATC

tramadol; systemic, rectal

1.8

61.1

1567

10708

68599

ICD-8 Finland

Pilonidal cyst

14.8

60.5

A10BA02

ATC

metformin; oral

1.9

60.5

911

5289

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

59.5

514

2423

J01CF05

ATC

flucloxacillin; systemic

2.6

57.8

356

1438

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

10.6

57.7

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

55.7

707

3858

J01MA02

ATC

ciprofloxacin; systemic

1.7

55.5

1341

8956

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

53.5

429

1955

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

53.4

1716

12341

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

6.3

50.5

137

N02BE01

ATC

paracetamol; systemic, rectal

1.9

48.7

3469

30430

A10AC01

ATC

insulin (human); parenteral

2.5

48.2

315

1307

6455

FHL

Perianal fistula surgery

15.9

47.8

T90

ICPC

Diabetes non-insulin dependent

1.9

47.7

735

4264

ZXE00

NOMESCO Finland

One hour or less

1.6

46.3

1393

9755

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

45.3

3018

25586

WX002

NOMESCO Finland

Sedation and analgesia

1.9

44.4

597

3303

6459

FHL

Other measure in this category

15.5

42.6

E66.8

ICD-10 Finland

Other obesity

2.5

42.2

292

1242

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

42.1

1212

8353

N07BA03

ATC

varenicline; oral

2.5

41.9

287

1215

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

3.8

41.1

128

346

A10AB05

ATC

insulin aspart; parenteral

2.3

40.2

323

1468

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

4.8

40.0

190

QXA05

NOMESCO Finland

Skin division, unspecified location

14.5

39.9

A10AE04

ATC

insulin glargine; parenteral

2.2

39.5

366

1763

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

5.6

39.0

134

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

38.8

1167

8097

S04

ICPC

Lump/swelling localized

2.0

38.0

454

2404

QBG99

NOMESCO Finland

Other operation for chronic ulcer or fistula of skin

134.6

37.8

SPAT1262

SPAT

Handing over of treatment supplies

1.9

37.1

534

3011

L03.9

ICD-10 Finland

Cellulitis, unspecified

4.8

36.4

173

G47.3

ICD-10 Finland

Sleep apnoea

1.6

35.7

984

6661

M79.6

ICD-10 Finland

Pain in limb

1.5

35.3

1611

12229

QBB99

NOMESCO Finland

Other procedure for wound of skin of trunk

13.3

34.8

J01MA12

ATC

levofloxacin; systemic

1.8

34.8

561

3275

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

5.9

34.3

104

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

33.7

644

3950

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

3.0

33.3

151

518

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

33.0

1717

13336

A10AB01

ATC

insulin (human); parenteral

2.6

32.8

189

736

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.1

32.8

344

1736

N03AX16

ATC

[U] pregabalin

1.7

32.5

705

4474

A10AE05

ATC

insulin detemir; parenteral

2.5

32.1

215

900

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.7

32.1

183

709

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.4

32.0

237

1039

A02BC02

ATC

pantoprazole; systemic

1.5

31.9

2340

19411

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

31.0

1445

10935

T89

ICPC

Diabetes insulin dependent

2.4

30.7

220

950

QBB10, ,

SPAT

4.8

30.4

143

L02.1

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of neck

6.4

30.3

K61

ICD-10 Finland

Abscess of anal and rectal regions

11.1

30.2

J01AA02

ATC

doxycycline; systemic

1.5

28.7

2746

23743

OAB50, ,

SPAT

2.1

28.4

292

1460

ZXD20

NOMESCO Finland

Day surgery

1.8

28.4

437

2506

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

28.4

198

844

JHD20

NOMESCO Finland

Incision of fistula-in-ano

4.3

27.9

166

M01AB05

ATC

diclofenac; systemic, rectal

1.4

27.8

2470

20989

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

27.7

2205

18352

T82

ICPC

Obesity

2.3

27.5

206

907

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

27.2

926

6525

A10AB04

ATC

insulin lispro; parenteral

2.6

26.9

162

645

H04AA01

ATC

glucagon; nasal, parenteral

2.7

26.7

149

571

J01AA07

ATC

tetracycline; systemic

1.6

26.5

643

4182

QWC00

NOMESCO Finland

Reoperation for superficial infection in surgery of skin

9.2

26.5

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

26.3

2995

26521

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

26.3

2078

17205

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

26.2

460

2741

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.1

26.0

175

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

26.0

881

6194

ZZR00

NOMESCO Finland

Flap of skin

4.5

25.9

142

9759

FHL

Other measure in this category

40.3

25.8

M01AE01

ATC

ibuprofen; systemic, rectal

1.8

25.8

3725

34749

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.8

25.6

454

2712

TNX30

NOMESCO Finland

Soft bandage, unspecified region

3.9

25.6

195

QDA10

NOMESCO Finland

Incision of skin of lower limb

7.8

25.5

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

25.5

1598

12672

L68.0

ICD-10 Finland

Hirsutism

5.8

24.9

UJF32

NOMESCO Finland

Coloscopy

1.6

24.9

707

4771

SPAT1153

SPAT

Removal of sutures

1.5

24.8

879

6231

A10AA02, ,

ATC

2.6

24.7

144

564

QBE05

NOMESCO Finland

Excision of sweat glands or sweat gland bearing skin from trunk

43.1

24.5

M54.5

ICD-10 Finland

Low back pain

1.4

24.3

1409

10987

L03.3

ICD-10 Finland

Cellulitis of trunk

5.9

24.3

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

24.1

410

2419

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.9

24.1

114

401

ABE30

NOMESCO Finland

Excision of dermal sinus

+∞

24.0

A46

ICD-10 Finland

Erysipelas

1.8

23.9

420

2502

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.1

23.9

160

N03AG01

ATC

valproic acid; systemic, rectal

2.0

23.8

251

1266

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.2

23.7

293

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.1

23.7

101

335

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

23.6

1174

8889

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.9

23.6

108

373

ZXD05

NOMESCO Finland

Urgent procedure

1.5

23.4

1029

7610

XCK10

NOMESCO Finland

Photography of fundus of eye

2.0

23.3

263

1360

N05AA02

ATC

levomepromazine; systemic

2.4

23.3

168

728

E66

ICD-10 Finland

Obesity

2.0

23.3

262

1354

N05AH02

ATC

clozapine; systemic

2.7

23.2

127

482

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

23.2

222

1080

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

23.2

977

7161

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

22.9

690

4709

S29

ICPC

Skin symptom/complaint other

1.6

22.7

645

4346

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

22.6

268

1410

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

5.3

22.5

H02AB06

ATC

prednisolone; systemic

1.4

22.5

1544

12362

N05AH04

ATC

quetiapine; oral

1.5

22.3

739

5150

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

22.3

132

522

SPAT1263

SPAT

Sampling

1.4

22.1

1402

11066

M01AE02

ATC

naproxen; oral, rectal

1.4

22.0

2112

17847

EBA00

NOMESCO Finland

Extraction of tooth

1.4

21.9

1442

11448

WX290

NOMESCO Finland

Other blockage of nerve

1.4

21.8

2143

18172

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

6.5

21.7

N05AX12

ATC

aripiprazole; systemic

2.0

21.7

240

1232

N05BA01

ATC

diazepam; systemic, rectal

1.7

21.6

398

2401

N06AB04

ATC

citalopram; systemic

1.6

21.5

659

4510

S76

ICPC

Skin infection other

2.2

21.3

179

827

Z3231

NOMESCO Finland

Registered nurse

1.5

21.3

853

6174

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

21.3

798

5699

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

21.3

1575

12732

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.1

21.2

206

1008

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

21.2

216

1076

SPAT1310

SPAT

Counselling related to known health issue

1.4

21.2

1009

7554

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

21.1

575

3831

M03BX02

ATC

tizanidine; oral

1.4

21.0

2377

20558

N05AH03

ATC

olanzapine; systemic

1.9

20.9

299

1672

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

20.8

335

1942

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

20.8

1805

14959

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.6

20.6

118

459

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

20.4

201

990

SGA01

NOMESCO Finland

Emergency treatment

1.5

20.2

762

5442

A10AA01, ,

ATC

2.5

20.1

131

542

SFA20

NOMESCO Finland

Two-surface restoration

1.4

20.0

2394

20807

8201

FHL

Ovarian preservation exploration and related procedures, eg resection, enucleation or ovariolysis

5.4

19.9

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

19.9

439

2775

A10BJ06

ATC

semaglutide; parenteral

2.1

19.9

201

998

C08CA01

ATC

amlodipine; oral

1.4

19.7

920

6846

UJH02

NOMESCO Finland

Anoscopy

2.4

19.6

137

586

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

19.6

195

964

J01DB05

ATC

cefadroxil; oral

2.1

19.4

176

839

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

19.2

985

7453

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

19.1

641

4464

N03AX12

ATC

[U] gabapentin; oral

1.6

19.1

474

3084

A10BK03

ATC

empagliflozin; oral

1.8

19.1

297

1705

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

19.0

741

5323

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

19.0

1037

7931

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

19.0

749

5394

M25.5

ICD-10 Finland

Pain in joint

1.4

18.9

1196

9375

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

18.8

2769

24734

N05AN01

ATC

lithium; oral

2.5

18.7

120

493

N03AX09

ATC

lamotrigine; oral

1.9

18.5

236

1273

C07AB07

ATC

bisoprolol; oral

1.4

18.3

1177

9245

SPAT1301

SPAT

No procedures

1.4

18.2

911

6850

N05BA04

ATC

oxazepam; oral

1.4

18.2

825

6093

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

18.2

802

5892

380

Kela drug reimbursment

Adalimumab (hidradenitis suppurativa)

21.8

18.1

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

17.9

251

1394

A03

ICPC

Fever

1.5

17.8

759

5539

Z72.0

ICD-10 Finland

Tobacco use

2.4

17.7

120

506

E66.9

ICD-10 Finland

Obesity, unspecified

2.2

17.7

148

684

S21

ICPC

Skin texture symptom/complaint

1.6

17.6

450

2948

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

3.1

17.6

239

J02AC01

ATC

fluconazole; systemic

1.4

17.4

1153

9084

ACC51

NOMESCO Finland

Release of median nerve

1.9

17.3

233

1279

SPAT1211

SPAT

Application of soft bandage

1.8

17.3

249

1396

N06AX16

ATC

venlafaxine; oral

1.5

17.0

539

3705

K02.1

ICD-10 Finland

Caries of dentine

1.3

16.8

2481

21964

C03CA01

ATC

furosemide; systemic

1.6

16.7

479

3218

N02BF01

ATC

gabapentin; oral

1.7

16.7

323

1970

A10AE06

ATC

insulin degludec; parenteral

2.1

16.7

153

733

N05AX08

ATC

risperidone; systemic

1.8

16.6

262

1510

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

16.5

679

4915

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.2

16.4

197

A06AD11

ATC

lactulose; oral

1.7

16.4

298

1789

QXB99, ,

SPAT

2.7

16.2

328

J04BA02

ATC

dapsone; oral

5.5

16.2

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

16.0

372

2379

J01CA04

ATC

amoxicillin; systemic

1.4

16.0

3239

29943

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.1

15.9

221

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

15.8

496

3398

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

15.8

422

2790

L17

ICPC

Foot/toe symptom/complaint

1.4

15.8

933

7199

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

15.7

420

2777

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

15.7

388

2519

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.0

15.6

164

827

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.0

15.6

229

SPAT1254

SPAT

Administration of medicine

1.6

15.4

396

2593

N06AB06

ATC

sertraline; oral

1.5

15.4

448

3017

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.4

15.4

102

427

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

15.3

178

930

R02

ICPC

Shortness of breath/dyspnoea

1.6

15.3

361

2317

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

15.2

625

4518

D06AX01

ATC

fusidic acid; topical

1.6

15.2

332

2090

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.7

15.2

299

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

15.1

1273

10360

K04.0

ICD-10 Finland

Pulpitis

1.5

15.1

432

2901

L70.0

ICD-10 Finland

Acne vulgaris

2.0

14.9

162

828

L15

ICPC

Knee symptom/complaint

1.4

14.9

749

5617

N02BF02

ATC

pregabalin; oral

1.8

14.8

229

1312

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

14.7

482

3331

N06AX11

ATC

mirtazapine; oral

1.3

14.6

1120

8979

P99

ICPC

Psychological disorders other

2.0

14.6

152

765

R03AC02

ATC

salbutamol; inhalant

1.3

14.5

1945

16836

L72.9

ICD-10 Finland

Follicular cyst of skin and subcutaneous tissue, unspecified

5.0

14.5

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

14.5

230

1328

A10BB12

ATC

glimepiride; oral

2.3

14.5

110

489

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

6.6

14.5

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

14.3

141

695

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.5

14.3

356

L03

ICPC

Low back symptom/complaint

1.3

14.2

1021

8100

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

14.2

270

1640

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

14.2

352

2286

N05CF01

ATC

zopiclone; oral

1.4

14.2

862

6664

A02BC05

ATC

esomeprazole; systemic

1.3

14.2

1231

10041

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.1

14.1

125

592

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

14.1

1239

10123

H01

ICPC

Ear pain/earache

1.5

14.1

436

2977

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

14.0

275

1685

D10BA01

ATC

isotretinoin; oral

1.6

14.0

345

2239

S01

ICPC

Pain/tenderness of skin

2.0

13.9

145

730

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

13.9

1258

10315

N06AX21

ATC

duloxetine; oral

1.5

13.9

391

2614

B01AB05

ATC

enoxaparin; parenteral

1.4

13.9

782

5969

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.2

13.8

166

M01AH05

ATC

etoricoxib; oral

1.3

13.7

2288

20307

N05AF03

ATC

chlorprothixene; systemic

2.3

13.7

105

468

A02BC03

ATC

lansoprazole; oral

1.4

13.7

733

5545

H36.01

ICD-10 Finland

Diabetic maculopathy

3.1

13.7

177

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

13.7

213

1223

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.9

13.7

100

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.4

13.7

382

C07AA05

ATC

propranolol; systemic

1.4

13.6

688

5156

L08

ICPC

Shoulder symptom/complaint

1.4

13.6

723

5466

N06AX12

ATC

bupropion; oral

1.6

13.5

359

2368

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

4.0

13.5

K61.2

ICD-10 Finland

Anorectal abscess

10.9

13.5

ZY010

NOMESCO Finland

Hospital outpatient

1.7

13.4

222

1299

L28

ICPC

Limited function/disability (L)

1.5

13.4

375

2505

Z2446

NOMESCO Finland

Social worker

1.7

13.3

222

1300

Z71.8

ICD-10 Finland

Other specified counselling

1.3

13.3

1223

10035

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

13.3

294

1856

SPAT1216

SPAT

Assessment of functional ability

1.6

13.3

296

1873

R06.0

ICD-10 Finland

Dyspnoea

1.4

13.3

728

5530

C09AA02

ATC

enalapril; systemic

1.5

13.2

380

2553

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.5

13.2

310

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

13.1

379

2548

L72.0

ICD-10 Finland

Epidermal cyst

2.9

13.1

214

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

13.1

873

6840

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

13.0

263

1624

5651A

ICD-9 Finland

Anal fissure and fistula, Anal fistula[FISTULA ANI]

11.0

13.0

SFA10

NOMESCO Finland

One-surface restoration

1.3

13.0

2153

19038

A01

ICPC

Pain general/multiple sites

1.6

13.0

278

1742

K04.08

ICD-10 Finland

Other specified pulpit

1.5

12.9

375

2523

L84

ICD-10 Finland

Corns and callosities

2.2

12.9

105

481

TQW99

NOMESCO Finland

Other minor procedure on skin

2.1

12.9

119

573

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.5

12.8

308

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

12.7

691

5236

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

12.7

911

7208

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.9

12.7

196

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.4

12.7

358

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

12.7

717

5470

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

12.6

181

1015

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

12.6

244

1490

BEF00, ,

SPAT

3.6

12.6

111

EB1VA, ,

NOMESCO Finland

1.4

12.6

664

5008

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

12.5

777

6013

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

12.5

173

959

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

12.5

966

7727

K61.1

ICD-10 Finland

Rectal abscess

5.2

12.5

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.9

12.4

157

845

6804

FHL

Removal of sacrococcygeal teratoma

130.4

12.4

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.5

12.4

307

R51.80

ICD-10 Finland

Headache

1.4

12.4

568

4179

N76.4

ICD-10 Finland

Abscess of vulva

4.3

12.4

J01DA06

ATC

[U] cefuroxime

1.5

12.3

441

3099

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

12.3

371

2518

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

12.2

637

4792

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

12.2

410

2845

A10BH01

ATC

sitagliptin; oral

1.7

12.2

208

1227

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

12.1

269

1701

R74

ICPC

Upper respiratory infection acute

1.3

12.1

1424

12035

J01FA06

ATC

roxithromycin; oral

1.3

12.1

1202

9941

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

12.1

452

3203

SPAT1283

SPAT

Restricted health certificate

1.3

12.1

795

6206

E0000UV, ,

ATC

1.3

12.1

1374

11565

A28

ICPC

Limited function/disability NOS

1.6

12.0

290

1871

SPAT1260

SPAT

Consultation of another employee

1.4

12.0

471

3370

K08.3

ICD-10 Finland

Retained dental root

1.7

11.9

241

1488

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.7

11.9

243

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

11.8

191

1109

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

11.8

278

1784

SFA30

NOMESCO Finland

Three-surface restoration

1.3

11.8

1475

12553

J01AA04

ATC

lymecycline; systemic

1.4

11.8

493

3569

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

11.7

134

698

Z2221

NOMESCO Finland

Medical doctor

1.3

11.7

824

6494

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.7

11.7

228

R50.9

ICD-10 Finland

Fever, unspecified

1.4

11.7

492

3565

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

11.7

512

3737

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

3.0

11.6

168

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.5

11.6

407

2847

WZC00, ,

SPAT

1.4

11.6

487

3525

C10AA07

ATC

rosuvastatin; oral

1.3

11.6

920

7373

M01AX17

ATC

nimesulide; oral

1.4

11.6

529

3889

C10AA05

ATC

atorvastatin; oral

1.3

11.5

1006

8171

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

11.5

724

5610

N03AF01

ATC

carbamazepine; oral, rectal

2.0

11.4

129

669

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.8

11.4

197

WX402

NOMESCO Finland

General anaesthesia

1.3

11.4

744

5794

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.8

11.4

182

1054

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

11.4

284

N05AB03

ATC

perphenazine; systemic, rectal

2.0

11.4

125

643

SPAT1229

SPAT

Assessment of need for aid

1.9

11.3

135

714

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

11.3

560

4176

C10AA01

ATC

simvastatin; oral

1.3

11.1

752

5886

ZXA05

NOMESCO Finland

Left side

1.4

11.1

572

4290

N75.1

ICD-10 Finland

Abscess of Bartholin gland

3.7

11.1

H13

ICPC

Plugged feeling ear

1.4

11.1

488

3562

J04AB02

ATC

rifampicin; systemic

3.3

11.1

121

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

11.0

194

1155

SPAT1255

SPAT

Intravenous administration of medicine

1.8

11.0

170

975

H3601, E103,

ICD-10 Finland

2.9

11.0

168

N05CD07

ATC

temazepam; oral

1.7

11.0

212

1294

L02

ICPC

Back symptom/complaint

1.5

10.9

386

2703

AA1AD

NOMESCO Finland

CT of head and brain

1.4

10.9

679

5245

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.1

10.9

474

N06AB10

ATC

escitalopram; oral

1.3

10.9

791

6252

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

10.9

269

1745

H3600, E103,

ICD-10 Finland

2.6

10.8

226

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

4.0

10.7

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

10.7

189

1126

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.0

10.7

120

622

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

10.7

315

2127

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

10.7

309

2078

D11

ICPC

Diarrhoea

1.4

10.6

461

3357

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

10.6

420

3007

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

10.6

419

3000

A10AD01

ATC

insulin (human); parenteral

2.5

10.6

258

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

10.5

366

2556

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.7

10.5

206

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

10.5

197

1194

WX702

NOMESCO Finland

Supraglottic ventilation device

1.7

10.5

181

1073

C05.9

ICD-10 Finland

Malignant neoplasm: Palate, unspecified

110.3

10.4

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.5

10.4

260

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.1

10.4

457

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

10.4

296

1985

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.2

10.3

373

-1, ,

NOMESCO Finland

1.3

10.3

1256

10612

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

10.3

486

3590

WX722

NOMESCO Finland

PEEP

1.9

10.3

128

687

L14

ICPC

Leg/thigh symptom/complaint

1.6

10.3

222

1395

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.3

10.2

117

M48.0

ICD-10 Finland

Spinal stenosis

1.6

10.2

220

1383

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

10.2

638

4934

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

10.1

231

1471

J01XC01

ATC

fusidic acid; systemic

2.8

10.1

171

D10AF01

ATC

clindamycin; topical

1.7

10.1

193

1177

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

10.1

230

1466

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

3.8

10.0

N05BA12

ATC

alprazolam; oral

1.5

10.0

276

1836

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.1

10.0

484

WZC30

NOMESCO Finland

Teaching

1.4

10.0

455

3339

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

10.0

422

3057

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.7

10.0

166

974

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

9.9

862

6976

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

9.9

102

513

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

9.9

781

6239

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.2

9.9

380

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

9.9

208

1300

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

9.8

262

1730

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

9.8

231

1484

A10BK01

ATC

dapagliflozin; oral

1.6

9.8

212

1334

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

9.8

305

2084

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.2

9.8

369

TQW80

NOMESCO Finland

Local dermatologic skincare

2.2

9.7

337

OAB74, ,

SPAT

3.0

9.7

142

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

9.7

206

1290

Z3226

NOMESCO Finland

Physiotherapist

1.4

9.7

480

3574

J46

ICD-10 Finland

Status asthmaticus

2.2

9.7

364

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.6

9.7

198

R11

ICD-10 Finland

Nausea and vomiting

1.5

9.6

259

1714

R05

ICPC

Cough

1.3

9.5

757

6051

8202

FHL

Oophorectomy

15.0

9.5

A02BC01

ATC

omeprazole; systemic

1.3

9.5

696

5501

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

9.5

389

2802

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

3.8

9.5

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

9.4

1477

12809

9473

FHL

Local soft tissue removal or exploration (eg Bursa)

4.1

9.4

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

9.4

292

1993

A07EA06

ATC

budesonide; oral, local oral

1.8

9.4

136

767

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

9.4

2711

25074

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.7

9.3

156

917

SPAT1240

SPAT

Therapeutic discussion

1.4

9.3

410

2991

N06AA09

ATC

amitriptyline; systemic

1.6

9.3

194

1209

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.0

9.3

450

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

4.5

9.3

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

4.5

9.3

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.4

9.3

250

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

9.3

104

540

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

9.2

173

1049

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.9

9.2

121

662

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

9.2

419

3075

M04AA01

ATC

allopurinol; systemic

1.5

9.2

255

1700

N02AA05

ATC

oxycodone; systemic

1.4

9.2

344

2438

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.2

9.2

110

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.3

9.2

105

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.3

9.2

105

D07AC01

ATC

betamethasone; topical

1.3

9.1

1121

9454

A10BB01

ATC

glibenclamide; oral

2.8

9.1

153

X58

ICD-10 Finland

Exposure to other specified factors

1.3

9.1

584

4527

ZXC10

NOMESCO Finland

Use of laser

2.3

9.1

309

A97

ICPC

No disease

1.3

9.0

613

4789

P72

ICPC

Schizophrenia

2.0

9.0

442

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

9.0

163

981

R60.0

ICD-10 Finland

Localized oedema

1.5

9.0

283

1939

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.2

8.9

107

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

8.9

622

4883

M01AC06

ATC

meloxicam; systemic, rectal

1.3

8.8

979

8152

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

1.9

8.8

514

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

4.9

8.8

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

8.8

466

3506

L16

ICPC

Ankle symptom/complaint

1.4

8.8

384

2797

IEV99

NOMESCO Finland

Other psychiatric network intervention

3.1

8.8

113

R4190

NOMESCO Finland

Nutritional therapy

1.8

8.7

137

791

SPAT1360

SPAT

Extensive global examination

1.7

8.7

155

927

H3603, E103,

ICD-10 Finland

2.7

8.7

168

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

8.7

266

1810

ZXA00

NOMESCO Finland

Right side

1.3

8.7

595

4654

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

8.7

156

936

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.1

8.7

354

N07BB01

ATC

disulfiram; oral

1.6

8.6

183

1146

L73.8

ICD-10 Finland

Other specified follicular disorders

2.6

8.6

192

L01

ICPC

Neck symptom/complaint

1.3

8.6

526

4046

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

8.6

224

1473

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

8.6

160

970

XF600, ,

SPAT

2.0

8.6

464

XCK00

NOMESCO Finland

Perimetry

1.8

8.6

119

663

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

8.5

200

1284

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

8.5

120

672

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.3

8.5

273

IEY01

NOMESCO Finland

Psychoeducation, individual

2.7

8.5

165

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

2.6

8.4

171

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.0

8.4

412

R06.5

ICD-10 Finland

Mouth breathing

1.4

8.4

334

2392

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

8.4

132

763

CL2S4, ,

SPAT

2.1

8.4

352

JN4AD

NOMESCO Finland

Body CT examination

1.5

8.4

248

1676

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

2.2

8.4

326

NH1AD

NOMESCO Finland

Ankle and foot CT

2.1

8.4

386

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

8.4

217

1426

SPAT1234

SPAT

Support of social functional capacity

1.9

8.4

105

567

WX704

NOMESCO Finland

Intubation

1.5

8.3

240

1613

N06AA10

ATC

nortriptyline; systemic

2.2

8.3

288

L08.0

ICD-10 Finland

Pyoderma

3.3

8.3

C09AA05

ATC

ramipril; oral

1.3

8.3

507

3898

R52.9

ICD-10 Finland

Pain, unspecified

1.4

8.3

306

2161

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.8

8.3

125

714

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

8.3

326

2332

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

8.3

193

1238

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

1.9

8.2

101

541

A29

ICPC

General symptom/complaint other

1.4

8.2

335

2410

2501B

ICD-9 Finland

Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]

3.8

8.2

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.3

8.2

258

ZX120

NOMESCO Finland

Intravenous

1.5

8.2

224

1488

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

8.2

899

7470

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

8.2

518

4006

IGY02, ,

SPAT

2.1

8.2

363

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.0

8.1

397

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

8.1

529

4105

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

8.1

956

8005

N45.0

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis with abscess

4.4

8.1

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.3

8.1

247

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.3

8.1

266

D01AA02

ATC

natamycin; topical

2.3

8.1

266

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.8

8.1

146

C07AB02

ATC

metoprolol; systemic

1.4

8.1

331

2384

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

3.2

8.1

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

8.0

243

1652

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

8.0

402

3000

Z00.0

ICD-10 Finland

General medical examination

1.3

8.0

580

4573

ZZA00

NOMESCO Finland

Split skin graft

2.3

8.0

262

L13

ICPC

Hip symptom/complaint

1.4

7.9

396

2951

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

3.3

7.9

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.7

7.9

129

755

6454

FHL

Incision of perianal abscess

13.0

7.9

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

7.9

205

1349

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

7.9

779

6391

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

7.8

133

787

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

7.8

123

712

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

7.8

154

948

A10BJ02

ATC

liraglutide; parenteral

2.0

7.8

418

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

7.8

312

2240

WVA20, ,

SPAT

1.8

7.8

104

574

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.0

7.8

439

A99

ICPC

Disease/condition unspecnature/site

1.5

7.7

278

1955

R03BB04

ATC

tiotropium bromide; inhalant

1.6

7.7

187

1210

JHD30

NOMESCO Finland

Incomplete incision of fistula-in-ano

4.2

7.7

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

2.5

7.7

185

N05AA01

ATC

chlorpromazine; systemic, rectal

2.5

7.7

191

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

7.7

234

1591

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

7.7

517

4029

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

1.9

7.7

475

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

7.7

657

5289

QXB05, ,

SPAT

3.1

7.7

101

J01MA01

ATC

ofloxacin; systemic

1.6

7.7

177

1133

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.2

7.6

273

D06

ICPC

Abdominal pain localized other

1.5

7.6

259

1801

205

Kela drug reimbursment

Chronic hypertension

1.4

7.6

410

3091

M02AA10

ATC

ketoprofen; topical

1.4

7.6

391

2927

CK2S4, ,

SPAT

2.4

7.6

205

L30.3

ICD-10 Finland

Infective dermatitis

1.8

7.6

107

601

7849C

ICD-9 Finland

Symptoms involving head and neck, Other symptoms involving head and neck[KUORSAUS]

4.1

7.5

R4120

NOMESCO Finland

Occupational therapy

1.6

7.5

178

1147

QDB10, ,

SPAT

2.2

7.5

256

1413

FHL

Laparoscopy and other therapeutic procedure

2.6

7.5

164

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

7.5

256

1783

P01

ICPC

Feeling anxious/nervous/tense

1.3

7.5

554

4377

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

7.4

1124

9657

N03AX11

ATC

topiramate; oral

1.9

7.4

432

6463

FHL

Perineal or sacroperineal plastics

80.2

7.4

J01CF02

ATC

cloxacillin; systemic

2.3

7.4

226

H60.0

ICD-10 Finland

Abscess of external ear

3.2

7.4

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

7.4

419

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

3.3

7.4

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.6

7.4

154

D07AC13

ATC

mometasone; topical

1.2

7.4

866

7244

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.0

7.3

104

KMAK, ,

NOMESCO Finland

1.2

7.3

1933

17512

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

7.3

163

1035

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

7.3

141

864

6805A

ICD-9 Finland

Carbuncle and furuncle, Buttock

+∞

7.3

68300

ICD-8 Finland

Acute lymphadenitis, Colli

+∞

7.3

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

3.6

7.3

T74.1

ICD-10 Finland

Physical abuse

1.9

7.3

435

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

7.3

421

SPAT1252

SPAT

Overall medication plan or its review

1.7

7.3

122

720

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

7.3

284

2029

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.0

7.3

366

SGB20

NOMESCO Finland

Root filling of tooth with onetwo root canals

1.5

7.3

250

1744

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.8

7.3

103

579

H29

ICPC

Ear symptom/complaint other

1.4

7.3

312

2267

B01AA03

ATC

warfarin; systemic

1.4

7.3

284

2030

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.5

7.2

173

D10

ICPC

Vomiting

1.5

7.2

251

1754

P17

ICPC

Tobacco abuse

2.3

7.2

241

J01FA01

ATC

erythromycin; systemic

1.3

7.2

490

3825

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.4

7.2

186

L70.1

ICD-10 Finland

Acne conglobata

3.6

7.1

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.6

7.1

150

940

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.4

7.1

205

R4110

NOMESCO Finland

Physiotherapy

1.3

7.1

755

6240

R5110, ,

SPAT

1.6

7.1

163

1043

L01BA01

ATC

methotrexate; systemic

1.9

7.1

439

OAB42, ,

SPAT

1.3

7.1

420

3214

WZC30, ,

SPAT

1.5

7.1

223

1530

SPAT1312

SPAT

General health counselling

1.2

7.0

962

8173

N05AX15

ATC

cariprazine; oral

3.0

7.0

M54.2

ICD-10 Finland

Cervicalgia

1.4

7.0

263

1865

L03.2

ICD-10 Finland

Cellulitis of face

3.6

7.0

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

7.0

102

579

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

7.0

130

790

C03DA01

ATC

spironolactone; oral

1.5

7.0

229

1584

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

7.0

250

1759

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

7.0

347

2586

K04.09

ICD-10 Finland

Pulpit UNS

1.5

6.9

190

1265

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

6.9

946

8034

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

6.9

111

647

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.2

6.9

265

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.6

6.9

140

869

CKC12

NOMESCO Finland

Photocoagulation of retina

1.7

6.9

113

663

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

4.0

6.9

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

1.9

6.9

444

F10.20

ICD-10 Finland

Alcohol dependence currently independent

1.9

6.9

416

M79.7

ICD-10 Finland

Fibromyalgia

1.8

6.9

509

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.5

6.8

195

1310

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

6.8

290

2103

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.8

6.8

105

605

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.5

6.8

160

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.3

6.8

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

4.1

6.8

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

6.8

169

1102

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.1

6.8

307

N05AE04

ATC

ziprasidone; systemic

2.6

6.8

137

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.0

6.8

341

A10AA03, ,

ATC

2.8

6.8

120

N05BE01

ATC

buspirone; oral

1.8

6.8

540

EBA30

NOMESCO Finland

Extraction of root of tooth

1.6

6.8

160

1031

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

6.8

1122

9716

N03AE01

ATC

clonazepam; systemic

1.6

6.8

147

929

K60

ICD-10 Finland

Fissure and fistula of anal and rectal regions

6.1

6.8

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

2.4

6.7

173

R96

ICPC

Asthma

1.5

6.7

237

1661

SGC10

NOMESCO Finland

Pulp capping

1.4

6.7

367

2773

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

6.7

305

2238

M54.8

ICD-10 Finland

Other dorsalgia

1.6

6.7

139

868

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.0

6.7

329

P76

ICPC

Depressive disorder

1.4

6.7

260

1856

L03.8

ICD-10 Finland

Cellulitis of other sites

3.9

6.7

Z50.1

ICD-10 Finland

Other physical therapy

1.7

6.7

120

722

L86

ICPC

Back syndrome with radiating pain

1.6

6.7

164

1066

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.2

6.7

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

6.7

264

1891

M02AA07

ATC

piroxicam; topical

1.2

6.7

838

7051

A08

ICPC

Swelling

1.7

6.7

108

632

7058C

ICD-9 Finland

Disorders of sweat glands, Other specified disorders of sweat glands[HIDRADENITIS SUPPURATIVA]

22.5

6.7

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.6

6.7

164

1067

B01AF01

ATC

rivaroxaban; oral

1.5

6.6

229

1599

G44.2

ICD-10 Finland

Tension-type headache

1.3

6.6

420

3246

A10BD07

ATC

metformin and sitagliptin; systemic

1.8

6.6

567

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.4

6.6

169

R95

ICPC

Chron obstructive pulmonary disease

2.2

6.6

251

S93

ICPC

Sebaceous cyst

3.1

6.6

H03AA01

ATC

levothyroxine sodium; systemic

1.3

6.6

508

4035

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.1

6.6

291

J01FA10

ATC

azithromycin; systemic

1.2

6.5

2124

19516

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

6.5

1331

11744

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.0

6.5

333

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

6.5

533

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.9

6.5

382

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

6.5

150

963

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

6.5

312

2313

L73.9

ICD-10 Finland

Follicular disorder, unspecified

3.1

6.5

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

1.9

6.4

411

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

3.2

6.4

D05BB02

ATC

acitretin; oral

2.0

6.4

321

L04AX01

ATC

azathioprine; systemic

1.6

6.4

136

855

T83

ICPC

Overweight

1.9

6.4

412

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

1.8

6.4

448

J01DC02

ATC

cefuroxime; systemic

1.5

6.4

164

1078

D07AD01

ATC

clobetasol; topical

1.3

6.4

434

3388

D12

ICPC

Constipation

1.9

6.4

413

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

6.3

223

1564

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

6.3

164

1080

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

6.3

295

2175

M23.8

ICD-10 Finland

Other internal derangements of knee

1.6

6.3

136

858

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

6.3

205

1416

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

2.9

6.3

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

1.8

6.3

472

SFA00

NOMESCO Finland

Small restoration

1.3

6.3

444

3484

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.3

6.3

360

2742

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.5

6.3

170

1131

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.7

6.3

576

H3602, E103,

ICD-10 Finland

3.8

6.3

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.7

6.2

577

A10BX04

ATC

[U] exenatide

3.0

6.2

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

6.2

236

1679

N05BA02

ATC

chlordiazepoxide; systemic

2.0

6.2

318

K11.2

ICD-10 Finland

Sialoadenitis

1.8

6.2

518

M75.5

ICD-10 Finland

Bursitis of shoulder

2.0

6.2

346

WX400

NOMESCO Finland

Inhalation anesthesy

1.6

6.2

120

738

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.8

6.2

482

5996

R55

ICD-10 Finland

Syncope and collapse

1.4

6.2

237

1690

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

6.2

128

801

H36.02

ICD-10 Finland

Preproliferative diabetic retinopathy

4.0

6.2

5660A

ICD-9 Finland

Abscess of anal and rectal regions[ABSCESSUS ANI ET ANORECTALIS]

6.3

6.2

A10BH02

ATC

vildagliptin; oral

2.7

6.1

121

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.6

6.1

132

833

A10BJ05

ATC

dulaglutide; parenteral

2.1

6.1

272

M10.9

ICD-10 Finland

Gout, unspecified

1.6

6.1

149

968

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

6.1

227

1608

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

6.1

879

7495

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1.8

6.1

462

C10AC01

ATC

colestyramine; oral

1.9

6.1

355

N05AD01

ATC

haloperidol; systemic

1.9

6.1

384

F61.0

ICD-10 Finland

Mixed personality disorders

2.0

6.1

321

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

2.3

6.1

176

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

6.1

144

931

D01

ICPC

Abdominal pain/cramps general

1.3

6.1

389

3013

N49.9

ICD-10 Finland

Inflammatory disorder of unspecified male genital organ

8.6

6.0

P19

ICPC

Drug abuse

2.3

6.0

195

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.5

6.0

172

1157

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

6.0

242

1739

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.6

6.0

124

774

SAE01, ,

NOMESCO Finland

2.1

6.0

247

R07.3

ICD-10 Finland

Other chest pain

1.4

6.0

286

2115

J01CA08

ATC

pivmecillinam; oral

1.2

6.0

880

7514

H02AB07

ATC

prednisone; oral

1.4

6.0

299

2228

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.9

6.0

378

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

6.0

634

5230

S56

ICPC

Skin, Dressing/pressure/compress/tamponade

3.5

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3042936) Bacteria identified in Isolate by Culture

899

4070

2.55

120.15

2.3

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

763

3536

2.42

94.79

1.9

1.6

—

(3012516) Albumin [Mass/volume] in Urine

1234

8560

1.63

41.64

4.2

3.6

63.88

49.43

mg/l

1.23

879

5831

(3009508) Creatinine [Moles/volume] in Urine

1440

10434

1.59

40.23

4.2

3.5

8.79

8.99

mmol/l

0.73

1251

9248

(3020682) Albumin/Creatinine [Ratio] in Urine

1241

8697

1.61

39.80

5.0

4.3

10.68

8.27

mg/mmol

1.01

858

5853

(3023368) Bacteria identified in Blood by Culture

1077

7298

1.65

39.53

4.6

4.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2834

24374

1.53

32.98

9.1

7.5

77.55

75.22

u/l

2.29

2716

23374

(3024561) Albumin [Mass/volume] in Serum or Plasma

1649

12798

1.48

31.30

6.1

5.2

36.70

37.19

g/l

3.19

1555

12099

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1590

12300

1.48

30.42

3.6

3.3

31.02

34.47

u/l

1.29

1505

11684

(3013826) Glucose [Moles/volume] in Serum or Plasma

2199

18168

1.46

29.59

6.4

4.9

6.93

6.51

mmol/l

11.03

2079

16981

(3023103) Potassium [Moles/volume] in Serum or Plasma

3652

33760

1.78

27.61

18.3

13.1

3.98

3.96

mmol/l

5.13

3589

33030

(3019550) Sodium [Moles/volume] in Serum or Plasma

3639

33621

1.76

27.36

18.1

13.0

139.62

139.70

mmol/l

1.40

3583

32961

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1302

9896

1.46

26.26

3.7

2.6

52.38

59.65

u/l

2.79

1222

9270

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3460

31685

1.61

25.24

6.7

5.0

40.09

37.89

mmol/mol

27.98

3325

30473

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1706

13703

1.42

25.23

8.7

7.0

1.21

mmol/l

0.20

1496

11945

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1939

15949

1.41

24.94

6.6

6.2

10.66

11.58

umol/l

2.11

1853

15233

(3032080) INR in Blood by Coagulation assay

1557

12450

1.41

22.96

12.1

9.8

1.17

1.16

inr

0.50

1301

10300

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1515

12123

1.40

21.98

8.2

6.6

1.21

mmol/l

0.26

1431

11356

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3693

34612

1.71

21.78

17.0

12.0

22.87

22.45

mg/l

0.32

3216

27623

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

312

1771

1.82

20.81

3.4

3.2

5.19

5.13

kpa

0.96

305

1704

(3009343) pH of Capillary blood

302

1726

1.81

19.69

3.3

3.2

7.41

7.42

1.90

249

1429

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

109

419

2.65

19.50

24.1

23.8

1462.68

1379.44

nmol/l

0.57

103

408

(3026493) Urate [Moles/volume] in Serum or Plasma

1101

8483

1.41

19.38

2.6

2.5

349.17

343.65

umol/l

1.10

1011

7786

(3013650) Neutrophils [#/volume] in Blood by Automated count

2215

19084

1.35

19.24

13.4

9.7

4.42

4.02

e9/l

13.27

1934

16707

(3013115) Eosinophils [#/volume] in Blood

2089

17881

1.34

18.73

9.1

7.0

0.19

e9/l

0.07

1875

15931

(3006315) Basophils [#/volume] in Blood

2028

17283

1.34

18.72

8.7

6.7

0.04

e9/l

0.79

1778

15157

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1121

8728

1.39

18.38

2.6

2.2

214.60

258.38

u/l

0.90

1069

8355

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1351

10843

1.37

18.37

3.5

2.9

173.20

49.83

ng/l

0.42

786

6066

(3019198) Lymphocytes [#/volume] in Blood

2072

17749

1.34

18.31

8.8

6.7

2.08

1.97

e9/l

2.90

1878

15941

(3001604) Monocytes [#/volume] in Blood

2022

17261

1.34

18.28

8.7

6.7

0.60

0.57

e9/l

10.13

1778

15146

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1760

14724

1.34

18.21

3.1

2.6

—

estimate

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2694

24029

1.36

18.01

4.6

3.9

10.38

8.61

mm/h

9.17

2558

22852

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2881

25975

1.37

17.92

4.6

3.9

14.54

14.51

pmol/l

0.24

2718

24410

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

615

4309

1.50

17.73

2.0

1.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3355

31069

1.45

17.64

5.6

4.6

1.75

1.78

mu/l

0.39

3206

29515

(3006504) Eosinophils/Leukocytes in Blood

1858

15739

1.33

17.36

8.7

6.8

2.65

2.83

3.66

1773

14954

(3019069) Monocytes/Leukocytes in Blood

1862

15785

1.33

17.28

8.8

6.8

8.51

8.71

2.88

1775

15003

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

262

1500

1.80

16.97

3.2

1.36

1.41

mmol/l

0.09

201

1090

(3002030) Lymphocytes/Leukocytes in Blood

1920

16389

1.32

16.80

8.6

6.7

28.67

29.10

1.08

1844

15732

(3022096) Basophils/Leukocytes in Blood

1850

15731

1.32

16.54

8.8

6.8

0.66

0.69

1.93

1756

14920

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3509

32871

1.48

16.47

14.6

11.0

93.89

91.83

ml/min/173m2

7.89

3218

29869

(3009466) Valproate [Moles/volume] in Serum or Plasma

128

574

2.27

16.45

6.5

377.07

374.84

umol/l

0.06

115

516

(3018010) Neutrophils/Leukocytes in Blood

1889

16130

1.32

16.30

8.4

6.6

57.26

56.41

2.75

1826

15573

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1677

14108

1.32

16.00

2.9

2.4

69.51

72.43

nmol/l

4.45

1570

13281

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

316

1940

1.68

15.97

1.7

—

(3015736) pH of Urine

1678

14151

1.32

15.60

3.4

2.9

6.16

0.08

999

8439

(3035350) Ketones [Presence] in Urine by Test strip

2011

17459

1.30

14.79

3.7

3.2

0.00

5.31

estimate

3.23

408

3484

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3853

37020

1.73

14.47

19.8

14.3

76.46

76.70

umol/l

0.16

3819

36687

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

154

781

2.01

14.47

1.8

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1164

9403

1.33

14.38

3.5

3.2

2.35

mmol/l

0.20

1084

8731

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1459

12184

1.31

14.17

2.0

1.9

99.18

97.04

pmol/l

1.04

852

6935

(3031040) Bacteria [#/volume] in Urine by Automated count

2251

19910

1.29

14.02

4.6

3.7

1187.79

997.35

e6/l

0.09

233

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1301

10714

1.31

13.94

3.6

3.1

—

1.26

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

453

3128

1.50

13.84

1.9

1.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

824

6350

1.37

13.78

2.8

3.0

1190.34

913.65

ng/l

0.49

643

5152

(3030467) Casts [#/volume] in Urine by Automated count

1029

8212

1.34

13.70

3.2

2.9

0.29

0.32

e6/l

0.19

755

5815

(3044640) Blood type and Crossmatch panel - Blood

1207

9856

1.32

13.69

2.9

2.2

—

(3044889) 12 lead EKG panel

2492

22380

1.29

13.57

3.6

3.3

0.20

12486.18

—

(3021601) Nitrite [Presence] in Urine by Test strip

1981

17288

1.28

13.49

3.7

3.2

0.00

estimate

0.80

406

3492

(3018095) Leukocytes [#/volume] in Urine

1369

11398

1.30

13.41

4.0

3.5

49.21

59.76

e6/l

0.36

949

7768

(3002582) Erythrocytes [#/volume] in Urine

1173

9570

1.32

13.32

3.4

3.0

46.02

88.16

e6/l

1.66

895

7158

(3027801) Oxygen [Partial pressure] in Arterial blood

439

3037

1.50

13.28

10.5

9.4

11.98

13.12

kpa

5.05

430

2924

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

439

3038

1.50

13.26

10.5

9.5

5.16

5.09

kpa

0.89

431

2925

(3009261) Glucose [Presence] in Urine by Test strip

2002

17526

1.28

13.17

3.7

3.2

0.01

0.10

estimate

0.49

366

3286

(3003458) Phosphate [Moles/volume] in Serum or Plasma

513

3671

1.45

13.07

8.5

6.8

1.06

1.03

mmol/l

1.67

485

3468

(3016502) Oxygen saturation in Arterial blood

394

2674

1.52

13.05

10.8

10.1

95.38

96.23

1.55

384

2588

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

177

976

1.85

13.00

2.2

2.5

416.37

448.70

ug/l

0.08

168

920

(3021960) Folate [Moles/volume] in Serum or Plasma

917

7266

1.34

12.67

1.7

1.6

18.40

19.34

nmol/l

1.40

818

6428

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3390

31888

1.37

12.55

4.9

4.1

6.12

5.78

mmol/l

26.66

3221

30196

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

430

2998

1.49

12.50

2.0

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

158

851

1.89

12.49

1.4

1.3

—

(3018418) pH of Serum or Plasma

1006

8093

1.32

12.49

5.1

4.0

7.40

0.03

722

5607

(3000850) Epithelial cells [#/volume] in Urine

812

6340

1.35

12.34

2.8

2.5

5.17

5.21

e6/l

0.03

755

5784

(3019977) pH of Arterial blood

433

3032

1.48

12.31

10.6

9.5

7.41

0.14

257

1639

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

941

7525

1.33

12.13

2.0

1.8

1.01

0.99

mg/l

0.09

705

5558

(3003396) Base excess in Arterial blood by calculation

428

3006

1.47

11.98

10.6

9.4

0.78

0.77

mmol/l

0.01

368

2451

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

560

4151

1.40

11.68

3.3

2.6

23.52

25.06

1.89

531

3908

(3012095) Magnesium [Moles/volume] in Serum or Plasma

634

4806

1.38

11.56

4.1

3.7

0.82

0.83

mmol/l

1.23

614

4593

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

924

7429

1.32

11.36

2.9

2.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3839

37071

1.60

11.30

13.0

10.0

31.80

29.92

u/l

5.41

3773

36358

(3012544) pH of Venous blood

392

2748

1.47

11.06

5.0

4.2

7.37

7.38

1.04

227

1519

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3661

35042

1.44

10.89

5.5

4.7

2.80

2.85

mmol/l

2.44

3505

33655

(3036481) Cortisol [Moles/volume] in Serum or Plasma

455

3292

1.43

10.86

2.4

2.2

366.69

373.46

nmol/l

0.31

428

3069

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1642

14250

1.25

10.85

2.0

1.8

1.59

1.46

mmol/l

3.82

1438

12615

(3017732) Neutrophils [#/volume] in Blood

555

4160

1.39

10.80

4.2

3.1

5.53

4.62

e9/l

0.85

506

3777

(3021447) Carbon dioxide [Partial pressure] in Venous blood

385

2704

1.47

10.75

5.2

4.1

5.87

5.84

kpa

0.22

378

2634

(3022313) Gas panel - Capillary blood

202

1225

1.68

10.73

3.5

3.4

—

(3002032) Base excess in Venous blood by calculation

376

2631

1.47

10.70

5.1

4.2

1.28

1.72

mmol/l

1.34

331

2286

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3643

34859

1.42

10.66

5.1

4.4

4.61

4.70

mmol/l

7.56

3502

33604

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

732

5740

1.34

10.65

1.3

9.27

8.93

u/ml

0.06

313

2431

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

829

6627

1.31

10.53

2.1

1.9

1.44

1.42

0.56

742

5965

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

798

6347

1.32

10.50

1.4

1.3

39.92

25.12

iu/ml

1.03

222

1828

(3028626) Oxygen [Partial pressure] in Capillary blood

124

656

1.92

10.41

2.8

3.1

8.70

8.59

kpa

0.34

124

641

(3048689) Calprotectin [Mass/mass] in Stool

677

5265

1.34

10.40

3.5

2.9

135.16

127.43

ug/g

0.27

551

4332

(3026008) Bacteria identified in Urine by Culture

841

6749

1.31

10.36

3.1

2.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

223

1403

1.62

10.28

1.8

1.6

—

(3026782) Osmolality of Urine

696

5445

1.34

10.26

3.0

2.6

556.15

562.05

mosm/kgh2o

0.28

622

4791

(3000494) Fungus identified in Specimen by Culture

544

4098

1.38

10.24

1.6

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

292

1961

1.53

10.15

3.7

2.9

76.43

71.28

e9/l

1.38

206

1415

(3004789) Transferrin [Mass/volume] in Serum or Plasma

590

4509

1.36

10.14

3.2

2.5

2.40

2.39

g/l

0.09

553

4221

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

705

5541

1.33

10.05

1.7

1.6

65176135.12

33839941.97

pmol/l

0.57

626

4873

(44816559) Phosphatidylethanol [Mass/volume] in Blood

324

2230

1.49

10.02

1.9

0.27

0.32

mg/l

0.99

160

1169

(3021589) Normoblasts [#/volume] in Blood

1722

15116

1.24

10.01

12.5

10.0

0.00

e9/l

1.43

1408

12393

(1616796) Gas panel - Central venous blood

117

617

1.92

9.93

3.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2953

27528

1.26

9.76

4.1

3.2

52.62

43.52

u/l

5.49

2853

26554

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3624

34743

1.39

9.59

5.0

4.3

1.29

1.38

mmol/l

42.42

3470

33365

(3037522) Nuclear Ab [Titer] in Serum

656

5146

1.33

9.43

1.4

584.19

503.04

titre

0.39

129

941

(3022948) Iron [Moles/volume] in Serum or Plasma

627

4905

1.33

9.17

3.2

2.5

14.07

14.85

umol/l

1.67

600

4627

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3452

32922

1.32

8.88

4.4

3.8

1.49

1.34

mmol/l

17.14

3301

31482

(3027945) Reticulocytes/Erythrocytes in Blood

373

2712

1.41

8.63

3.5

2.9

1.76

1.72

0.35

342

2464

(3019309) Folate [Moles/volume] in Red Blood Cells

488

3715

1.36

8.55

1.8

1.7

1086.95

1136.92

nmol/l

0.69

394

2939

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

116

3.03

8.41

2.4

2.1

14.85

15.32

umol/l

0.08

116

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

118

663

1.80

8.28

1.1

55.63

892.64

iu/ml

0.52

154

(3027273) Bicarbonate [Moles/volume] in Venous blood

173

1084

1.62

8.16

3.2

3.3

25.15

25.16

mmol/l

0.01

167

1042

(3019150) Specific gravity of Urine by Refractometry

930

7766

1.26

8.11

4.0

3.1

1.02

1.42

kg/l

0.80

619

4972

(3014111) Lactate [Moles/volume] in Serum or Plasma

349

2541

1.41

8.02

11.4

9.3

1.33

1.34

mmol/l

0.10

344

2492

(3029937) Albumin [Presence] in Urine by Test strip

1059

8984

1.24

8.00

3.9

3.3

0.00

estimate

2.17

381

3254

(3011397) Hemoglobin [Presence] in Urine by Test strip

881

7321

1.26

8.00

3.7

3.2

0.00

0.17

—

(3033658) Prothrombin time (PT) actual/Normal

973

8188

1.25

7.90

4.9

4.1

92.80

92.43

0.19

951

8030

(3011288) Drugs identified in Urine by Screen method Nominal

309

2208

1.43

7.89

3.8

2.8

—

(40758558) Short blood count panel - Blood

1107

9455

1.23

7.83

7.5

6.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

110

616

1.81

7.82

2.6

2.5

99.47

121.39

ug/min

0.17

417

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1541

13619

1.21

7.76

3.4

3.0

0.01

0.02

estimate

0.34

340

2958

(3016244) Insulin [Units/volume] in Serum or Plasma

278

2.21

7.74

3.4

3.5

26.91

27.36

mu/l

0.04

261

(3019225) pH of Specimen

315

2268

1.42

7.71

3.7

3.8

7.35

0.20

258

1702

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

424

3209

1.36

7.70

4.3

4.0

29.31

30.18

0.85

315

2345

(3024354) Oxygen [Partial pressure] in Venous blood

314

2263

1.42

7.65

4.1

3.5

4.87

4.76

kpa

0.45

306

2203

(3017143) Hepatitis C virus Ab [Presence] in Serum

730

5968

1.27

7.56

1.9

1.7

—

(3004809) Band form neutrophils/Leukocytes in Blood

417

1.96

7.47

3.3

3.6

2.05

1.33

0.43

386

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

606

4847

1.29

7.46

3.3

2.8

2.43

2.42

mmol/l

0.80

543

4362

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

150

929

1.64

7.45

2.0

1.22

2.08

ug/l

0.97

137

843

(3045414) Leukocytes [Presence] in Urine

353

2625

1.38

7.16

2.0

1.9

0.07

0.02

estimate

0.59

647

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

204

1372

1.51

7.11

1.5

1.4

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

314

2294

1.40

7.09

1.4

—

(3003129) Base excess in Capillary blood by calculation

309

2.09

7.06

1.6

1.9

0.10

0.38

mmol/l

0.36

300

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

401

3058

1.35

6.93

4.4

4.8

223.25

233.27

u/l

0.91

374

2928

(3042517) Benzodiazepines panel - Urine

3.45

6.83

2.5

2.4

—

(3000991) Gas panel - Venous blood

326

2424

1.37

6.63

13.9

10.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

354

2671

1.36

6.56

3.4

2.7

—

(3014007) Fractional oxyhemoglobin in Arterial blood

250

1780

1.43

6.54

13.8

12.0

93.77

94.30

0.72

250

1772

(3028707) Methadone [Presence] in Urine by Screen method

186

1254

1.51

6.44

4.1

2.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

289

2118

1.39

6.42

4.0

4.7

17.03

20.42

ug/l

0.18

226

1663

(3014051) Protein [Presence] in Urine by Test strip

1158

10101

1.20

6.41

2.7

2.4

0.08

0.03

0.25

124

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

199

1365

1.48

6.34

1.7

1.6

0.38

0.18

iu/ml

0.28

223

(3017354) Segmented neutrophils/Leukocytes in Blood

262

2.11

6.32

3.0

3.8

57.71

56.18

0.23

237

(3004119) Hemoglobin [Mass/volume] in Venous blood

235

1666

1.44

6.31

4.0

3.5

134.03

135.64

g/l

0.42

227

1629

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

477

3778

1.30

6.30

2.8

2.9

9.20

7.25

umol/l

0.70

401

3320

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1028

8904

1.21

6.08

1.4

1.3

1.33

1.75

u/ml

0.65

312

2600

(3007461) Platelets [#/volume] in Blood

3963

38949

1.61

6.07

26.4

18.3

256.53

252.28

e9/l

4.16

3911

38336

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

664

5500

1.25

6.06

4.1

3.4

292.05

522.43

ng/l

1.20

423

3631

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

221

2.19

6.02

1.6

5813333.17

1437921.56

iu/ml

—

(3020779) Urea [Moles/volume] in Serum or Plasma

333

2523

1.35

6.02

10.6

8.5

9.43

8.36

mmol/l

1.95

322

2441

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3964

38966

1.61

6.01

26.2

18.2

90.23

90.04

2.09

3937

38699

(3035941) MCH [Entitic mass]

3964

38968

1.61

5.98

26.2

18.1

30.23

0.11

3937

38699

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1079

9403

1.20

5.96

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

115

708

1.64

5.92

1.4

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3964

38973

1.60

5.91

27.0

18.6

42.01

42.70

1.44

3936

38684

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

244

1763

1.41

5.91

6.1

4.5

101.86

84.42

ng/l

1.51

219

1615

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

616

5077

1.25

5.87

2.8

2.6

1.12

0.95

e6/l

0.37

299

2526

(3026361) Erythrocytes [#/volume] in Blood

3964

38977

1.60

5.86

26.3

18.2

4.70

4.69

e12/l

1.06

3900

38298

(3000963) Hemoglobin [Mass/volume] in Blood

3965

38994

1.60

5.79

26.5

18.3

141.26

140.91

g/l

0.79

3939

38726

(3010813) Leukocytes [#/volume] in Blood

3964

38986

1.59

5.74

26.4

18.3

7.14

6.65

e9/l

33.03

3898

38295

(3022145) Colonoscopy Study observation

467

3734

1.28

5.73

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

328

1.94

5.72

1.6

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

114

708

1.63

5.69

4.2

3.7

0.34

iu/ml

0.06

363

(3002256) Pathology report gross observation

483

3883

1.28

5.68

1.3

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

572

4706

1.25

5.53

3.0

2.8

5.10

2.06

e6/l

1.64

250

2140

(3005719) IgG [Mass/volume] in Serum or Plasma

366

2852

1.31

5.46

2.8

2.7

10.47

10.68

g/l

0.47

334

2663

(3028026) IgM [Mass/volume] in Serum or Plasma

289

2176

1.35

5.46

1.9

1.8

1.32

1.25

g/l

0.15

265

2056

(3009214) Lutropin [Units/volume] in Serum or Plasma

252

1858

1.38

5.44

1.6

1.5

6.33

7.35

u/l

1.25

213

1488

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

236

1722

1.39

5.42

14.4

12.2

0.61

0.65

1.16

236

1710

(3020630) Protein [Mass/volume] in Serum or Plasma

259

1921

1.37

5.39

2.4

66.50

67.38

g/l

1.33

244

1823

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

330

1.89

5.30

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

331

1.89

5.25

1.7

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

346

1.86

5.22

1.7

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

395

3129

1.29

5.22

3.0

2.6

40.97

55.63

u/l

0.43

336

2701

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

147

990

1.50

5.18

2.2

2.0

—

(40768797) Stomach Pathology biopsy report

508

4156

1.25

5.15

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

341

1.86

5.13

1.7

1.4

—

(3047181) Lactate [Moles/volume] in Blood

126

824

1.55

5.10

5.8

6.7

1.22

1.28

mmol/l

0.50

112

709

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

239

1767

1.37

5.09

14.2

12.0

1.56

1.36

1.58

239

1758

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

524

1.67

4.94

1.4

7.08

6.82

mmol/l

0.45

479

(3007164) IgA [Mass/volume] in Serum or Plasma

907

7898

1.19

4.94

1.5

2.32

2.35

g/l

0.19

610

5412

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

218

1601

1.38

4.85

15.4

12.1

24.23

24.26

mmol/l

0.04

213

1572

(3052851) Hemolysis interference index of Serum or Plasma

115

746

1.56

4.84

3.7

2.9

1.60

2.33

index

0.89

408

(3024522) Salmonella sp identified in Specimen by Organism specific culture

342

1.83

4.78

1.7

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

331

2593

1.30

4.77

2.9

2.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

101

638

1.60

4.77

1.4

1.5

372.75

345.53

mu/l

0.23

511

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

228

1693

1.37

4.74

6.1

4.5

23.83

24.24

mmol/l

1.17

223

1681

(3000570) Elastase.pancreatic [Mass/mass] in Stool

125

832

1.52

4.69

1.5

1.4

286.71

293.70

ug/g

0.13

464

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

133

898

1.50

4.67

2.1

1.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

491

4047

1.24

4.66

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

151

1048

1.46

4.62

5.6

6.1

1.00

0.89

0.24

145

984

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

450

1.70

4.62

1.4

1.3

0.14

0.25

nmol/l

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

346

2739

1.29

4.61

2.9

2.5

0.22

0.23

g/l

2.96

327

2570

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

165

1165

1.43

4.61

1.2

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

854

7440

1.19

4.59

2.4

2.2

2.71

2.60

mg/l

0.87

777

6508

(3002179) Metamyelocytes/Leukocytes in Blood

336

2656

1.29

4.54

5.7

4.8

0.56

0.69

0.70

127

718

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

164

1163

1.43

4.49

5.3

5.7

1.94

1.73

1.10

159

1095

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

945

8321

1.18

4.47

1.8

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

199

1461

1.38

4.46

2.3

2.2

—

(3021440) Promyelocytes/Leukocytes in Blood

336

2662

1.29

4.46

6.0

5.1

0.03

0.12

3.57

118

645

(3017181) Myelocytes/Leukocytes in Blood

348

2771

1.28

4.44

5.9

5.0

0.82

0.94

0.31

130

753

(3006184) Hemoglobin [Mass/volume] in Capillary blood

636

1.57

4.38

2.3

2.1

140.74

137.31

g/l

0.74

507

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

276

2136

1.31

4.37

2.8

2.6

3053.72

6076.27

u/l

2.02

866

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

260

1.90

4.30

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

247

1.91

4.24

3.7

4.1

—

(4146454) Self-monitoring of blood glucose

240

1.93

4.24

2.8

2.6

—

(3045424) Erythrocytes [Presence] in Urine

195

1441

1.37

4.22

2.1

2.0

0.06

0.51

estimate

0.44

504

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

262

1.88

4.21

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

380

1.72

4.17

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

121

822

1.49

4.16

6.6

6.0

409.86

677.36

iu/ml

0.40

104

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

115

2.36

4.15

2.0

2.8

30.44

29.56

umol/l

0.12

(3048929) Epstein Barr virus Ab [Presence] in Serum

230

1749

1.33

4.14

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

630

1.55

4.12

3.6

3.2

2419.40

1407.03

u/ml

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

427

1.67

4.11

1.4

283.81

338.69

pmol/l

0.94

368

(3041096) Erythrocytes [Presence] in Urine by Automated

1155

10398

1.15

4.04

2.9

2.6

0.04

estimate

0.07

337

2836

(3037756) Immunofixation for Serum or Plasma

407

1.68

4.02

1.9

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

146

1038

1.42

3.98

2.0

1.7

0.25

0.23

g/l

0.88

140

989

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

181

1339

1.37

3.91

1.4

1.3

—

(3035715) Granulocytes [#/volume] in Blood

606

1.55

3.91

4.0

3.6

4.30

4.04

e9/l

0.58

606

(3007463) Buprenorphine [Presence] in Urine

4.79

3.86

9.0

5.3

—

(3037121) Protein [Mass/volume] in Urine

143

1023

1.41

3.78

3.7

3.8

424.12

369.41

mg/l

0.18

519

(3025159) Blasts/Leukocytes in Blood

336

2722

1.26

3.75

6.2

5.3

0.09

0.33

0.80

113

613

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

254

1990

1.29

3.72

2.3

2.2

5.53

8.90

ug/l

3.00

222

1811

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

175

2.01

3.68

2.0

98.83

163.58

umol/l

1.03

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

260

2047

1.29

3.67

3.6

3.4

1.22

mmol/l

0.16

224

1782

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

114

787

1.46

3.66

2.3

2.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.43

3.63

1.9

2.3

—

(3008295) Osmolality of Serum or Plasma

298

1.75

3.62

1.2

1.6

283.32

283.71

mosm/kgh2o

0.04

233

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

108

740

1.47

3.61

4.0

2.3

0.98

0.86

nmol/l

0.86

637

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

514

1.57

3.60

1.8

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

101

683

1.49

3.60

3.4

4.4

3.88

3.91

mmol/l

0.29

101

678

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

321

1.72

3.60

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

129

915

1.42

3.60

1.3

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

116

807

1.45

3.59

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

329

1.71

3.58

1.7

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

376

1.66

3.53

1.4

1.3

0.19

0.24

nmol/l

0.54

291

(3012501) Base excess in Blood by calculation

590

1.52

3.50

3.8

3.6

2.45

2.21

mmol/l

0.27

372

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

582

1.52

3.50

2.8

3.2

2.34

2.82

ratio

0.20

317

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

250

1.81

3.49

1.0

1.2

59.92

59.28

u/l

0.03

223

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

553

1.53

3.42

1.2

1.3

21.53

32.01

u/l

0.63

477

(3028300) Cannabinoids [Presence] in Urine

400

3337

1.22

3.42

2.7

2.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

252

1.79

3.40

1.2

1.1

101.09

112.10

pmol/l

0.86

252

(3023420) DNA double strand Ab [Units/volume] in Serum

191

1458

1.33

3.40

2.0

1.8

6.60

5.95

iu/ml

0.15

364

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

133

2.11

3.39

1.5

1.7

150.00

136.87

au/ml

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

174

1.96

3.38

1.3

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

396

3307

1.22

3.35

2.8

2.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.84

3.35

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

398

1.62

3.33

3.8

2.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

406

1.61

3.32

2.0

1.4

1.45

1.38

promille

0.13

321

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

126

905

1.40

3.30

1.2

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

322

1.69

3.30

1.5

1.3

1.39

1.36

nmol/l

0.07

295

(3014765) Yersinia sp identified in Stool by Organism specific culture

126

907

1.40

3.27

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

374

3116

1.22

3.25

2.8

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

610

1.49

3.21

1.2

1.21

0.95

—

(3027008) Opiates [Presence] in Urine

396

3329

1.21

3.15

2.8

1.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.41

3.13

1.3

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

268

2163

1.26

3.13

3.4

3.7

4.62

4.63

pmol/l

0.08

252

1968

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

325

2681

1.23

3.12

1.3

1.2

133.93

146.74

u/ml

0.24

125

989

(3017446) Testosterone [Moles/volume] in Serum or Plasma

604

5277

1.17

3.09

2.8

2.4

12.29

14.28

nmol/l

10.08

556

4943

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

120

868

1.39

3.05

1.6

1.5

4588.23

933.75

e6/l

0.48

680

(3024139) IgG subclass 3 [Mass/volume] in Serum

400

1.58

3.04

1.4

1.3

0.44

0.38

g/l

0.75

283

(3028192) IgG subclass 2 [Mass/volume] in Serum

401

1.58

3.01

1.4

1.3

3.43

3.08

g/l

0.82

285

(3027135) IgG subclass 1 [Mass/volume] in Serum

401

1.58

3.01

1.4

1.3

6.26

6.45

g/l

0.22

284

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

103

728

1.43

2.99

1.5

1.4

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.64

2.96

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

148

1114

1.34

2.95

3.4

2.9

3.94

3.50

g/l

2.10

143

1064

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1295

11951

1.12

2.94

4.0

1.49

1.78

ug/l

2.32

1193

11058

(3016750) Collection duration of Urine

155

1.94

2.94

2.3

2.5

502.72

502.23

min

0.01

120

(4062490) Immunoglobulin typing, IgG

396

1.57

2.93

1.4

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

574

1.47

2.92

1.4

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3135

30407

1.13

2.89

20.7

14.8

13.43

13.31

6.78

3101

30033

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

117

852

1.38

2.88

1.6

1.5

26.77

25.84

e6/l

0.03

632

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

651

1.44

2.86

2.9

3.4

33.01

52.71

mg/l

0.58

555

(3028308) Erythrocytes [#/volume] in Pleural fluid

178

1.86

2.86

1.5

1.4

25582.22

58555.82

e6/l

0.67

(40760892) CBC W Ordered Manual Differential panel - Blood

962

8734

1.13

2.85

5.7

4.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

127

939

1.36

2.85

1.9

2.1

3.40

3.79

iu/l

0.39

416

(3034860) Kappa light chains.free [Mass/volume] in Serum

652

1.44

2.84

3.0

3.4

48.32

53.16

mg/l

0.17

555

(3027923) C peptide [Moles/volume] in Serum or Plasma

193

1.82

2.83

1.4

1.6

1.40

1.38

nmol/l

0.03

143

(3007566) Smooth muscle Ab [Titer] in Serum

153

1165

1.33

2.83

1.2

1.3

63.33

93.18

titre

—

129

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

419

4881

0.84

2.82

1.6

3.63

3.52

mmol/l

0.97

276

3272

(3023511) Choriogonadotropin [Units/volume] in Urine

134

1002

1.35

2.80

1.7

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

301

1.64

2.73

2.7

3.2

2.17

22.57

nmol/l

0.57

291

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

145

1102

1.33

2.73

1.8

1.9

1.50

1.41

g/l

0.60

126

966

(3018677) aPTT in Platelet poor plasma by Coagulation assay

505

4397

1.17

2.71

2.9

2.3

29.65

29.47

0.29

491

4283

(3024263) Appearance of Synovial fluid

139

1.95

2.69

1.3

1.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

117

865

1.36

2.65

3.2

4.2

1719.98

1823.29

u/ml

0.02

104

764

(3030981) Hyaline casts [#/volume] in Urine by Automated count

272

2244

1.23

2.64

2.9

2.3

0.22

0.39

e6/l

1.65

262

2129

(3012441) Differential panel - Pleural fluid

183

1.81

2.64

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.80

2.64

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

440

1.51

2.62

1.1

—

(3027944) Amphetamines [Presence] in Urine

386

3297

1.19

2.61

2.7

1.9

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

555

1.45

2.61

1.2

977.50

505.41

titre

—

(3032057) Clostridioides difficile [Presence] in Stool

3.34

2.60

2.0

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

290

1.63

2.59

1.3

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

515

1.46

2.58

1.7

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.30

2.57

4.5

6.6

—

604.60

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

283

1.63

2.57

1.3

1.1

—

(3008898) HLA-B27 [Presence]

209

1682

1.26

2.56

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.73

2.54

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

785

0.65

2.53

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

476

1.48

2.53

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

208

1.74

2.53

1.6

1.4

3149.70

2865.17

e6/l

0.11

140

(1002224) Polysomnography panel

321

2705

1.20

2.53

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

126

951

1.34

2.51

1.3

25.48

10.51

u/ml

0.34

131

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.27

2.50

1.0

1.1

1.75

6.26

u/ml

2.32

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

478

1.47

2.49

1.5

1.9

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.98

2.48

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

232

1.69

2.48

3.7

3.5

8.93

8.79

mg/l

0.05

190

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1796

16988

1.10

2.46

3.5

3.1

133.49

115.79

ug/l

0.98

1722

16229

(40757373) Influenza virus identified in Isolate

2.67

2.45

1.5

1.8

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

563

1.43

2.44

1.2

—

268.75

—

(3035933) Granulocytes/Leukocytes in Blood

105

775

1.36

2.43

4.0

3.3

57.59

57.85

0.07

105

775

(3002079) Sodium [Moles/time] in 24 hour Urine

181

1.77

2.43

1.2

1.4

176.53

182.26

mmol/24h

0.13

181

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

101

741

1.37

2.43

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

125

948

1.33

2.42

1.3

1.2

27.47

3.39

u/ml

0.43

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

265

1.63

2.41

2.1

2.0

34.26

20.90

mg/l

0.82

114

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

236

2854

0.82

2.40

1.6

795.82

1001.61

mu/l

3.22

193

2417

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

128

976

1.32

2.40

1.4

595.56

508.59

mg/l

0.68

123

935

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

133

1021

1.31

2.38

1.4

1.2

12.74

29.27

u/ml

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

115

1510

0.75

2.34

1.5

1.10

1.19

ratio

0.33

918

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

115

1510

0.75

2.34

1.5

0.93

0.94

ratio

0.15

913

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

115

1507

0.76

2.31

1.5

1.13

1.15

ratio

0.07

910

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

573

6418

0.88

2.30

1.9

3.91

3.70

ratio

2.58

431

4842

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

114

1493

0.76

2.28

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

155

1222

1.28

2.28

3.0

2.4

96.16

94.08

0.51

150

1182

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.75

2.27

7.5

9.1

6.88

6.07

mmol/l

0.24

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

208

1699

1.24

2.26

2.5

2.7

157.13

126.21

ng/l

0.50

184

1491

(3004451) EKG impression Narrative

134

1.87

2.26

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

355

3052

1.18

2.26

6.7

5.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

623

1.39

2.25

2.2

0.00

g/l

-0.00

599

(3014891) Appearance of Pleural fluid

3.89

2.25

2.1

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

448

1.46

2.24

1.5

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

407

1.48

2.24

1.2

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

100

744

1.35

2.23

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

693

1.36

2.22

2.2

0.03

0.02

g/l

0.03

647

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

220

1813

1.23

2.21

1.5

1.4

—

(3022621) pH of Urine by Test strip

287

2428

1.20

2.20

2.7

2.0

6.08

6.12

0.39

193

1472

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

107

1.97

2.20

1.9

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

107

1.97

2.20

1.9

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

500

1.43

2.19

1.9

2.0

5.34

5.45

mmol/24h

0.10

463

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

126

1618

0.77

2.19

1.5

59.01

60.44

ug/l

0.11

1367

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.29

2.15

1.0

1.4

300.62

561.33

nmol/l

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

204

1.67

2.14

1.3

71.75

74.57

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

314

1.53

2.13

1.4

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.21

2.10

1.2

—

(3034092) Cytoplasmic Ig cells/cells in Blood

2.56

2.07

10.5

6.7

0.18

0.19

0.10

(3025941) Bacteria identified in Stool by Culture

257

2166

1.20

2.07

1.3

1.2

—

(3024928) Oxygen saturation in Venous blood

102

772

1.33

2.06

5.0

4.1

68.80

65.05

1.12

751

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

784

7166

1.12

2.05

2.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1135

10578

1.10

2.04

2.2

2.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

441

1.44

2.03

1.5

1.3

—

(40761536) Microorganisms panel - Urine sediment

308

2644

1.18

2.02

3.5

3.3

—

(3017569) Oxygen content in Arterial blood

125

1.84

2.02

2.8

2.4

16.58

17.06

0.31

125

(3045788) Cell count panel - Pleural fluid

177

1.70

2.02

1.7

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

188

1541

1.23

2.01

2.2

40.52

39.96

u/l

0.13

173

1425

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

102

775

1.32

2.01

2.2

0.38

0.75

g/l

0.94

707

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

115

889

1.30

2.00

2.0

2.1

3.98

3.78

g/l

0.76

107

846

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

115

889

1.30

2.00

2.0

2.1

7.40

7.13

g/l

1.12

107

846

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

115

889

1.30

2.00

2.0

2.1

4.22

4.25

g/l

0.19

107

845

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

271

1.56

2.00

1.3

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

155

1.75

2.00

2.1

1.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

165

1335

1.25

1.99

1.2

2.66

0.87

u/ml

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

110

846

1.31

1.99

2.1

2.2

3.03

2.88

g/l

0.88

102

803

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

299

2565

1.18

1.98

2.4

13.08

19.80

au/ml

2.10

361

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

148

1.76

1.98

1.7

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

136

1077

1.27

1.97

1.0

1.1

0.96

5.34

eliau/ml

3.17

187

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

103

787

1.32

1.96

1.3

1.2

52.96

37.24

u/ml

0.30

(3018333) Ribosomal P Ab [Presence] in Serum

265

1.55

1.94

1.4

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

112

867

1.30

1.94

1.3

3.87

3.68

mmol/l

1.03

107

823

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

615

1.36

1.94

1.5

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

149

1.75

1.94

1.7

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

280

2395

1.18

1.93

1.5

1.4

16.19

20.58

iu/l

2.51

241

2001

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

102

781

1.31

1.92

2.1

2.2

10.22

10.31

g/l

0.07

735

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

141

1127

1.26

1.91

3.4

3.8

1.54

1.31

mg/l

2.06

129

1058

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

643

1.34

1.90

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

150

1.74

1.90

1.1

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

704

1.33

1.90

1.4

1.7

0.69

0.80

g/l

0.57

561

(3004775) Volume in Urine collected for unspecified duration

189

1.65

1.87

2.8

2.5

629.81

656.74

0.16

136

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

664

1.33

1.84

2.2

0.01

0.00

g/l

0.34

600

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1254

0.77

1.82

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

100

1287

0.77

1.82

1.6

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

281

2422

1.17

1.79

3.2

2.4

77.43

76.93

ml/min/173m2

0.06

113

915

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

496

1.38

1.78

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

496

1.38

1.78

1.3

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

252

2154

1.18

1.77

1.8

1.7

282.34

279.02

mu/l

0.06

236

1967

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

288

1.50

1.76

1.1

—

(3005033) Fetal Nuchal fold Thickness US

1236

0.77

1.76

1.5

1.31

1.26

0.42

903

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

125

996

1.26

1.76

1.4

1.3

256.20

245.12

u/ml

0.16

643

(3014271) Vancomycin [Susceptibility]

2.09

1.75

3.4

2.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

313

1.48

1.75

3.1

6.2

8.39

7.15

mmol/l

0.84

262

(3006653) Thiamine [Moles/volume] in Blood

185

1.63

1.75

1.5

1.4

141.20

136.48

nmol/l

0.26

185

(3020876) Protein [Mass/time] in 24 hour Urine

297

1.49

1.74

2.4

2.8

1.53

1.71

g/24h

0.21

191

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

281

1.50

1.74

1.4

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

602

1.34

1.73

3.5

2.9

23.48

25.12

mg/l

0.19

407

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

282

1.49

1.71

1.4

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.13

1.71

1.4

1.2

1.19

1.17

mmol/l

0.23

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

274

1.50

1.71

1.4

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2855

27819

1.09

1.70

3.6

3.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

754

1.29

1.67

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

400

1.41

1.67

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

188

1.60

1.65

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

196

1.59

1.65

1.6

2.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.93

1.64

1.4

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

112

1.79

1.64

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.25

1.63

1.4

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

261

1.50

1.63

1.3

1.1

1606.10

1444.88

miu/ml

0.40

261

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

146

1197

1.23

1.62

2.1

2.2

—

(3000060) B lymphocytes [#/volume] in Blood

120

1.75

1.62

1.8

2.0

0.14

0.18

e9/l

—

(3000475) Leukocytes [#/volume] in Synovial fluid

671

1.30

1.60

1.5

1.6

10023.59

15716.07

e6/l

0.82

477

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

206

1.56

1.59

3.4

2.7

274.47

141.21

au/ml

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.00

1.58

4.2

7.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

167

1.62

1.58

1.3

1.1

116.62

190.12

iu/ml

1.66

167

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

431

1.37

1.56

1.4

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.85

1.55

1.8

2.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

322

1.43

1.55

1.2

1.3

38.00

238.95

titre

—

(4198724) Urine methamphetamine measurement

306

1.44

1.53

2.5

2.6

—

(3000012) Reticulocyte production index

298

1.45

1.53

3.0

1.9

1.00

0.91

0.62

193

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

747

1.28

1.53

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.34

1.52

2.8

4.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

835

7775

1.09

1.51

2.3

—

(40768806) Pleura Pathology biopsy report

177

1.59

1.51

1.8

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

112

900

1.25

1.51

1.8

1.5

—

(3036489) Thrombin time

165

1381

1.20

1.51

3.0

2.3

20.92

20.68

0.21

145

1206

(3003327) Ova and parasites identified in Stool by Light microscopy

176

1484

1.19

1.49

1.6

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

359

1.40

1.48

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

142

1174

1.22

1.48

3.7

2.4

23.08

40.48

u/ml

2.17

134

1128

(3011412) CD3 cells [#/volume] in Blood

334

1.41

1.47

2.3

2.6

1370.08

1297.67

e6/l

0.20

292

(3024891) Influenza virus A+B Ag [Presence] in Specimen

146

1211

1.21

1.47

1.1

—

(3020491) Glucose [Moles/volume] in Blood

251

1.48

1.47

2.6

1.6

7.29

6.31

mmol/l

0.72

183

(3006442) Creatine [Moles/volume] in Serum or Plasma

244

1.48

1.44

1.7

1.4

72.81

80.29

umol/l

2.00

244

(40768441) Liver Pathology biopsy report

236

1.49

1.44

1.5

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

172

1.57

1.42

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

273

2399

1.15

1.40

1.3

24.19

50.78

au/ml

1.61

159

(3003434) Protein [Mass/volume] in Pleural fluid

246

1.47

1.39

1.5

1.4

33.70

33.99

g/l

0.06

221

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

598

1.29

1.39

1.1

1.49

1.45

g/l

0.44

556

(3000093) Morphology [Interpretation] in Blood Narrative

263

1.45

1.38

1.2

1.1

—

(36660697) Celiac disease serology panel - Serum

339

3025

1.13

1.38

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.08

1.38

1.9

2.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.61

1.36

1.5

2.2

257.50

272.93

ug/l

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

796

1.25

1.36

1.8

1.7

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.15

1.33

1.1

1.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

257

1.44

1.33

2.6

3.0

232.29

233.14

e6/l

0.01

219

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

128

1.64

1.33

1.8

2.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

585

1.29

1.32

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

222

1933

1.16

1.31

2.2

2.0

191.83

216.75

pmol/l

3.26

212

1857

(3024869) Neuronal Ab [Presence] in Serum

2.36

1.29

1.0

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

226

1.46

1.28

1.7

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

226

1.46

1.28

1.7

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

226

1.46

1.28

1.7

1.9

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

361

1.36

1.28

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

677

1.26

1.28

1.2

1.3

2.58

3.67

u/ml

0.62

247

(3033099) Centromere Ab [Titer] in Serum

1.94

1.27

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

252

1.43

1.26

4.1

2.2

30.64

30.01

mg/l

0.03

179

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

128

1068

1.20

1.25

1.1

3.24

3.96

0.99

219

(3013139) Helicobacter pylori Ag [Presence] in Stool

254

2244

1.14

1.23

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

338

1.37

1.23

1.3

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.00

1.23

1.0

1.6

—

(40768446) Kidney Pathology biopsy report

163

1.54

1.22

2.0

1.7

—

(3045142) Bone marrow Pathology biopsy report

279

1.40

1.22

1.4

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

254

1.42

1.21

1.9

2.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.72

1.21

2.1

1.4

9.20

8.39

ug/l

0.35

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

103

850

1.22

1.15

1.9

1.5

117.32

150.30

au/ml

1.81

227

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

571

1.27

1.15

1.5

1.4

120.36

99.40

pmol/l

0.12

557

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

105

869

1.21

1.14

1.6

1.8

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3242

31921

1.08

1.13

21.5

14.8

334.35

334.82

g/l

2.23

3220

31742

(3023410) Appearance of Cerebral spinal fluid

397

1.31

1.11

1.9

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

199

1746

1.15

1.09

1.4

1.3

215.50

218.69

miu/ml

0.04

821

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

647

1.24

1.09

1.2

1.1

126.64

114.01

2.46

600

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

162

1401

1.16

1.09

2.2

1.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

193

1.45

1.09

1.4

1.5

—

(3024471) HLA-A [Type]

136

1.55

1.08

1.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

128

1.57

1.08

1.8

2.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

128

1.57

1.08

1.8

2.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

128

1.57

1.08

1.8

2.4

—

(3024932) HLA-DR beta [Type]

137

1.54

1.05

1.0

1.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.27

1.03

2.0

4.8

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

473

1.27

1.03

5.5

4.1

316.42

225.34

u/ml

0.28

434

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

107

0.47

1.01

1.0

1.1

14.40

46.27

iu/ml

—

107

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

493

1.26

1.00

1.9

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.00

1.00

1.0

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

992

9454

1.07

0.98

3.5

3.4

21.52

21.34

0.11

345

3437

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.84

0.98

1.0

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.81

0.98

1.0

1.3

356.83

294.29

pmol/l

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.18

0.98

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1143

0.84

0.98

1.1

5.99

6.19

u/ml

0.03

621

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

666

1.22

0.97

1.3

3.19

4.21

u/ml

0.68

318

(3033799) Differential panel - Peritoneal fluid

1.67

0.97

1.4

1.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

108

1272

0.84

0.97

1.1

1.05

2.26

u/ml

2.14

650

(3004716) Salmonella sp identified in Stool by Organism specific culture

226

2022

1.12

0.95

1.3

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

381

1.29

0.95

1.9

1.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

706

1.21

0.94

1.3

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

125

1.52

0.93

1.2

31.50

13.42

—

(3042733) HLA Ab [Presence] in Serum

158

1.46

0.93

7.9

5.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1114

0.84

0.92

1.1

1.01

1.92

u/ml

1.40

548

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

252

1.35

0.91

2.6

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

165

1868

0.88

0.90

1.5

1.4

—

(3003694) ABO and Rh group [Type] in Blood

1159

11131

1.06

0.89

1.5

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

117

1356

0.86

0.88

1.6

—

(37208534) Antinuclear antibody arbitrary concentration in serum

111

1.53

0.87

1.1

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

360

1.28

0.87

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

686

1.20

0.86

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1116

0.85

0.86

1.7

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1062

0.84

0.86

1.5

59.19

59.83

ug/l

0.05

1062

(4035726) Immunohistochemistry procedure

249

2258

1.11

0.85

1.3

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.94

0.84

1.3

1.8

252.50

306.19

umol/24h

—

(3042631) Mycobacterium sp identified in Specimen

300

1.30

0.84

1.7

2.7

—

(4268621) Lupus anticoagulant assay

470

1.24

0.83

2.3

2.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

283

1.31

0.83

1.1

1.02

1.07

u/l

0.38

115

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.88

0.81

1.5

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.55

0.81

1.6

2.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

914

0.84

0.80

1.1

11.75

4.49

u/ml

0.43

405

(40768443) Skin Pathology biopsy report

143

1261

1.14

0.79

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

207

1.36

0.79

1.8

1.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.82

0.79

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

242

1.32

0.78

2.8

2.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.67

0.78

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1105

0.86

0.78

1.1

0.54

0.94

u/ml

1.21

474

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

0.00

0.77

0.0

1.7

—

9.86

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

234

1.33

0.77

1.5

1.8

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

111

965

1.15

0.76

2.6

2.3

10.82

10.71

mg/l

0.06

103

920

(3028433) Virus identified in Specimen by Culture

1.54

0.75

1.0

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

597

6300

0.94

0.75

1.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

253

1.31

0.75

2.5

2.8

522.79

560.53

e6/l

0.14

207

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.60

0.74

1.1

1.3

99.17

91.45

0.35

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.08

0.74

1.6

3.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

227

1.32

0.74

2.1

1.4

6.00

7.14

u/l

0.57

197

(21494434) Karyotype in Bone marrow

201

1.35

0.74

1.2

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

469

1.22

0.73

3.1

3.3

—

(3049717) Cytology report of Urine Cyto stain

820

1.16

0.72

2.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

125

1.44

0.72

1.0

1.5

84.64

103.28

nmol/24h

0.37

125

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

159

1.39

0.72

1.4

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

117

1.45

0.71

1.5

2.6

56.18

107.45

ng/l

3.93

117

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.92

0.70

1.6

2.3

—

(3020393) Adenovirus Ag [Presence] in Stool

1.92

0.70

1.0

1.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.92

0.70

2.2

4.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.71

0.70

1.0

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

319

1.26

0.69

1.4

1.2

0.66

0.67

ratio

0.03

180

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

695

6635

1.06

0.67

1.6

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

144

1.39

0.67

1.0

228.14

266.12

ng/l

0.56

102

(3014133) Dog dander IgE Ab [Units/volume] in Serum

971

0.86

0.66

1.1

2.89

3.66

u/ml

0.42

484

(4024509) Urine culture

124

1100

1.13

0.66

2.0

1.7

—

(3017704) Immunofixation for Urine

111

1.44

0.65

1.7

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

111

1.44

0.65

3.5

3.2

0.97

1.30

0.56

111

(3032773) Endomysium IgG Ab [Titer] in Serum

376

1.23

0.65

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

277

1.27

0.65

1.1

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.61

0.65

1.2

1.3

64.00

65.69

ug/l

—

(4281824) Cell count and differential, peritoneal fluid

198

1.32

0.64

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

278

1.26

0.63

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

164

1.34

0.62

3.0

—

(3038026) Centromere Ab [Units/volume] in Serum

226

1.29

0.61

1.2

—

47.91

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.60

0.61

1.1

1.0

—

(21494814) CD8 cells/Lymphocytes in Specimen

130

1.39

0.61

1.6

2.2

27.33

30.42

0.50

130

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

113

1.42

0.61

1.4

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.60

0.0

1.0

—

35.12

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.60

0.0

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

621

1.16

0.59

1.4

18.48

19.66

u/l

0.15

520

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

157

1.34

0.59

1.4

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.44

0.59

1.6

2.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.44

0.59

1.6

2.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

345

1.22

0.58

1.1

1.0

0.55

1.14

u/ml

—

(3013762) Body weight Measured

0.00

0.58

0.0

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

140

1.36

0.58

1.0

1149.08

793.71

ng/l

1.23

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

762

7331

1.05

0.57

2.5

2.6

0.62

0.68

ug/l

1.47

376

3733

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

147

1333

1.11

0.57

1.2

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

220

1.27

0.56

1.2

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

229

1.27

0.56

4.5

2.8

0.79

0.84

nmol/l

0.37

176

(1617658) Protocol used for examination of sentinel lymph nodes

149

0.67

0.56

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.62

0.55

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

374

3531

1.07

0.55

2.3

2.2

—

(44790048) Parainfluenza type 2 nucleic acid detection

421

1.19

0.55

1.9

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

330

1.21

0.54

1.1

1.0

0.39

1.57

u/ml

0.46

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.58

0.54

1.3

1.8

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.58

0.54

1.3

1.0

0.01

0.11

u/ml

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

142

1.34

0.54

1.0

22.77

35.12

ng/l

1.70

(3020874) Milk IgE Ab [Units/volume] in Serum

340

1.21

0.53

1.1

1.0

1.59

1.97

u/ml

0.09

100

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

227

0.75

0.53

1.2

—

(3020650) Glucose [Presence] in Urine

134

1.34

0.53

1.2

1.4

0.17

0.04

estimate

0.32

134

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.43

0.52

1.0

1.4

0.17

0.18

nmol/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.62

0.52

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.50

0.51

1.3

1.8

—

(4034850) Laboratory test

102

913

1.12

0.51

9.9

7.9

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

325

0.80

0.50

2.9

3.4

39.96

44.65

0.60

325

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.41

0.50

1.2

1.1

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

324

0.80

0.49

5.7

6.8

10.54

8.64

0.78

324

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

408

1.18

0.49

1.3

1.2

54.25

41.40

mg/l

1.24

336

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

101

1.39

0.49

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.56

0.49

1.3

5.40

5.68

mmol/l

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.56

0.49

1.0

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

838

0.88

0.48

1.1

0.10

0.23

u/ml

1.08

246

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.52

0.48

1.0

—

(3047189) Immunofixation for 24 hour Urine

1.40

0.48

1.2

2.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

786

1.12

0.47

1.1

7.95

14.09

au/ml

1.00

269

(3003181) Sodium [Moles/volume] in Urine

401

1.17

0.47

1.4

63.87

66.67

mmol/l

0.16

319

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

365

0.82

0.47

1.4

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.46

0.46

1.3

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.46

0.46

1.3

1.0

—

(4195642) Thrombophilia screening test

645

1.13

0.46

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

218

1.24

0.46

1.3

5.34

6.03

mmol/l

0.63

201

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

1.43

0.46

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.38

0.46

2.1

1.2

—

(44790047) Parainfluenza type 1 nucleic acid detection

421

1.17

0.45

1.9

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

421

1.17

0.45

1.9

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

421

1.17

0.45

1.9

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

219

1.23

0.45

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

329

1.19

0.45

1.6

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

242

2273

1.07

0.45

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

441

1.16

0.44

1.1

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

166

1.27

0.43

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

116

1061

1.10

0.42

1.5

—

(3023419) Bacteria identified in Sputum by Culture

332

1.18

0.41

4.2

2.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.36

0.41

1.2

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.52

0.41

1.2

1.5

29.66

35.95

nmol/l

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.36

0.41

1.5

1.4

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.19

—

(3002523) Influenza virus A Ag [Presence] in Specimen

120

1102

1.09

0.40

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

110

1006

1.10

0.40

1.6

1.5

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.47

0.40

1.0

0.03

0.15

u/ml

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

132

1.29

0.40

1.9

1.8

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.36

0.40

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

120

1103

1.09

0.40

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

441

4233

1.05

0.40

2.4

2.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

113

1231

0.92

0.39

1.9

1.8

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.43

0.39

1.0

—

0.12

u/ml

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.38

0.38

1.5

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.36

0.38

1.9

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.36

0.38

2.6

4.3

3.22

4.47

ug/l

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

107

1.31

0.37

3.2

2.9

0.65

0.61

mmol/l

1.00

107

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.35

0.37

1.0

1.1

0.08

0.02

u/ml

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

116

1.29

0.37

1.3

1.9

—

216.80

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

782

1.10

0.36

2.9

2.7

9.67

14.29

titre

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

374

1.15

0.36

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.27

0.36

1.0

2.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.40

0.35

1.0

1.1

—

(21494755) Public health laboratory ask at order entry panel

586

6045

0.96

0.35

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

255

0.82

0.35

1.9

2.0

10.89

2.83

u/ml

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

376

1.15

0.35

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

235

2475

0.95

0.34

1.8

1.6

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.34

0.34

1.3

1.1

7.47

0.48

u/ml

0.44

(3015956) Eosinophils/Leukocytes in Blood by Manual count

1.33

0.33

1.2

1.7

1.67

3.82

—

(40758292) HTLV I+II Ab panel - Serum

1.32

0.33

1.2

1.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

306

0.85

0.32

1.7

1.6

49.61

56.98

0.42

192

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

175

0.80

0.30

2.6

1.9

—

(3051611) Lipemic interference index of Serum or Plasma

240

1.17

0.30

3.8

3.4

14.00

14.87

index

0.14

172

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

388

0.88

0.29

1.1

28.39

18.50

u/ml

0.98

181

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.25

0.29

7.7

7.6

9.74

11.21

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

160

1690

0.94

0.28

1.8

5.01

3.87

mg/l

0.53

136

1190

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

259

0.85

0.28

1.2

9.36

6.97

mm/h

0.40

259

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.28

0.28

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

124

1165

1.07

0.27

2.9

2.7

1.02

ratio

0.50

114

1049

(3010375) cycloSPORINE [Mass/volume] in Blood

168

1.19

0.27

28.4

24.1

147.71

120.31

ug/l

0.81

138

(4211845) Urine protein measurement

128

0.78

0.26

1.4

2.5

—

(40765096) Chromosome analysis panel by Banding

1.28

0.26

1.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.28

0.26

1.2

1.3

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

0.70

0.26

1.0

1.4

55.00

55.10

—

(3002619) Bacteria identified in Specimen by Culture

1.30

0.26

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

141

1.21

0.26

1.4

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

132

1.21

0.25

1.9

2.3

8.81

7.77

mmol/l

0.39

132

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

293

1.13

0.24

1.7

2.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

523

1.09

0.23

1.2

1.4

—

9.93

—

(40762365) Oxygen content in Arterial blood by calculation

1.25

0.22

5.4

3.4

16.18

15.14

ml/dl

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.75

0.22

1.1

1.2

46.00

66.09

ug/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

617

0.92

0.21

1.2

1.4

181.99

196.98

pmol/l

0.27

617

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

229

1.14

0.21

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

2.8

—

1.65

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

51.47

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.21

0.0

1.5

—

4.60

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.21

0.0

1.0

—

133.86

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

604

1.08

0.21

1.8

1.6

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.0

—

2.23

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

9.7

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

2.25

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

145

1.17

0.20

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

1.15

0.19

1.3

1.0

1.31

1.02

u/ml

—

(1761868) Lipid panel - Serum or Plasma

1710

17249

0.99

0.18

2.9

2.7

—

(3018133) Calcium [Moles/volume] in Urine

1.15

0.17

1.4

2.0

2.40

2.44

mmol/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.75

0.17

1.0

1.2

—

(44813793) Dust mix specific IgE antibody measurement

263

1.10

0.16

1.1

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.13

0.16

1.1

—

(40768800) Prostate Pathology biopsy report

535

1.07

0.16

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

197

1.12

0.15

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.14

0.15

1.0

113.32

80.08

ug/l

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

234

0.90

0.15

1.6

1.5

20.29

30.54

0.97

138

(3044007) Cell count panel - Peritoneal fluid

1.10

0.15

2.0

2.1

—

(4038314) Semen analysis, post vasectomy

1.19

0.14

1.5

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

832

1.05

0.14

1.5

0.42

nmol/l

0.01

663

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

334

1.08

0.13

3.9

5.6

371.31

72.30

u/ml

0.38

110

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

180

1.11

0.13

1.0

1.1

104.87

96.43

0.67

148

(3006462) Nitrate [Presence] in Urine

107

0.84

0.13

1.4

2.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.16

0.11

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.16

0.11

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.16

0.11

1.0

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

178

0.90

0.11

5.1

3.0

22.81

193.91

ug/l

0.69

164

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

236

2409

0.98

0.11

1.1

0.69

0.68

ratio

0.06

225

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

136

0.88

0.11

1.0

1.1

—

6.50

—

(44806420) Estimation of glomerular filtration rate

434

0.94

0.10

2.4

2.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

208

0.91

0.10

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

164

1.10

0.09

2.3

1.8

1.30

1.52

u/field

—

100

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

116

1.12

0.09

1.5

1.3

—

63.64

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.13

0.09

1.3

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

233

1.07

0.09

7.4

9.0

35.86

10103.94

u/ml

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.11

0.09

1.3

1.0

17.79

0.88

u/ml

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

1.09

0.08

2.5

3.2

574.00

1429.12

u/l

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

705

1.04

0.08

3.5

2.3

13.07

13.05

0.07

699

(3010144) Erythrocytes [#/volume] in Synovial fluid

247

0.93

0.08

1.3

1.4

26778.92

101023.42

e6/l

1.13

173

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

302

1.06

0.08

1.3

1.1

—

1.50

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

643

0.96

0.08

1.1

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

266

0.94

0.07

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.05

0.07

6.9

6.5

4.74

5.57

kpa

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

186

1.08

0.07

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

147

1.09

0.07

1.3

1.5

9.80

5.92

u/l

—

125

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

121

0.91

0.06

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

121

0.91

0.06

1.5

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

583

1.03

0.05

1.1

1.33

2.76

1.76

144

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

100

1.10

0.05

1.3

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

664

1.02

0.05

1.0

1.1

3.94

3.06

eliau/ml

0.20

377

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

120

1.08

0.04

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.10

0.04

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.10

0.04

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.10

0.04

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.10

0.04

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

249

1.04

0.04

2.8

2.7

45.97

45.31

0.07

124

(40768793) Breast Pathology biopsy report

493

0.97

0.04

1.2

1.3

—

(3034426) Prothrombin time (PT)

141

1.06

0.03

1.1

1.2

29.07

28.89

0.03

141

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

240

0.96

0.03

4.5

4.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

693

0.98

0.03

2.1

2.4

4.57

5.75

umol/l

0.62

512

(3009871) Measles virus Ab [Titer] in Serum

191

1.05

0.03

1.5

1.7

3840.00

2043.08

titre

—

(4094501) Cardiovascular stress test using bicycle ergometer

933

0.99

0.03

1.0

1.1

—

(4133840) Spirometry

138

0.94

0.02

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

281

1.03

0.02

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

162

1.05

0.02

1.1

422.00

177.33

ng/l

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

258

0.97

0.02

1.3

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

183

1.04

0.01

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

247

0.97

0.01

1.4

1.5

0.49

0.51

e9/l

0.17

247

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

1.05

0.00

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

334

1.02

0.00

2.4

206.28

417.12

pmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

485

4843

1.00

0.00

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

158

1.01

0.00

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

172

0.99

0.00

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

288

1.01

0.00

1.0

1.1

16.76

7.59

iu/ml

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

285

1.02

0.00

1.1

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

263

2625

1.00

0.00

1.5

1.3

338.80

265.44

u/ml

0.26

246

2455

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

301

1.00

0.00

1.3

0.82

1.62

u/ml

0.50

157

(3038177) Helicobacter pylori Ab [Presence] in Serum

739

1.00

0.00

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.04

0.00

2.9

4.7

—

(3025130) Human papilloma virus identified in Specimen

556

1.01

0.00

2.2

1.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

546

1.01

0.00

1.2

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

141

1413

1.00

0.00

1.7

25.26

11.18

u/ml

1.07

451

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

217

1.01

0.00

2.5

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

137

1.02

0.00

1.1

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

143

0.98

0.00

2.4

3.7

18.99

72.69

u/ml

1.60

143

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.2

—

174.00

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.00

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.93

0.00

1.2

1.0

0.01

1.14

u/ml

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.01

-0.00

1.3

1.7

41.83

42.16

g/l

—

(3017509) Phencyclidine [Presence] in Urine

1.01

-0.00

2.6

1.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.96

-0.00

2.4

3.3

10.59

10.51

kpa

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

2.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.99

-0.00

1.4

1.1

4.03

11.02

u/ml

—

(44806071) Cardiolipin IgM antibody measurement

0.89

-0.00

1.0

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

7855.22

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.86

-0.00

1.2

1.0

0.50

0.43

u/ml

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3044927) Protein electrophoresis panel - Urine

190

1.00

-0.00

1.8

1.1

—

(3047185) IgG [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

0.89

-0.00

1.2

1.4

—

206.00

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.89

-0.00

2.2

1.6

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.96

-0.00

2.4

3.3

5.03

4.86

kpa

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

7.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

2.36

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.3

—

1.17

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_PILONIDALCYST and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_PILONIDALCYST	1.434 [1.18, 1.74]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 162 out of 6711 females with L12_PILONIDALCYST died.

Males

Parameter	HR [95% CI]	p-value
L12_PILONIDALCYST	1.341 [1.19, 1.51]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.011

During the follow-up period (1.1.1998 — 31.12.2019), 792 out of 18376 males with L12_PILONIDALCYST died.

Mortality risk

Mortality risk for people of age

years, who have L12_PILONIDALCYST.

N-year risk	Females	Males
1	0.127%	0.249%
5	0.809%	1.604%
10	1.803%	3.91%
15	3.667%	7.756%
20	5.968%	12.828%

Relationships between endpoints

↥

Index endpoint: L12_PILONIDALCYST – Pilonidal cyst

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pilonidal cyst

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints